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Figure 5.6 Conductivity response from MCF-7 cells ([cell] = 146 cells/ µl using tris-
glycine buffer as the suspension medium and at a flow rate of 0.05 µl/min. Upper panel 
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Figure 5.7 Video frame image acquired with video microscope showing a tumor cell as 
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Figure 5.8 Conductivity response from WBCs (cell density =150 cells/µL in tris-glycine 
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Figure 5.10 Top (labeled A) is the schematics of the HTMSU showing the integrated 
conductivity sensor (labeled B), a single port exit for detached cells (labeled C) and the 
sinusoidal cell capture channels (labeled D). Bottom (labeled E) is the conductivity 
response from a 1.0 mL of whole blood spiked with 10 CTCs and processed in the 
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pumped through the device at a flow rate of 0.05 μL/min) and enumeration of the CTCs. 
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Cp………………………………………………………………………….parasitic capacitance 
DNA……………………………………………………………………... Deoxyribonucleic acid 
DE…………………………………………………………………………..Detection Efficiency 





DTCs………………………………………………………………..Disseminated Tumor Cells 
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The realization of high throughput sample processing has become a primary 
ambition in many research applications with an example being high throughput 
screening (HTS), which represents the first step in the drug discovery pipeline. 
Microfluidics is a viable platform for parallel processing of biochemical reactions to 
increase data production rates due to its ability to generate fluidic networks with a high 
number of processors over small footprints suitable for optical imaging. Single-molecule 
detection (SMD) is another technology which has emerged to facilitate the realization of 
high throughput data processing afforded by its ability to eliminate sample processing 
steps and generate results with high statistical accuracy. A combination of microfluidics 
and SMD with wide-field fluorescence detection provides the ability to monitor 
biochemical reactions in a high throughput format with single-molecule sensitivity. In this 
dissertation, the integration of these techniques was presented for HTS applications in 
drug discovery.  
An ultra-sensitive fluorescence detection system with a wide field-of-view (FoV) 
was constructed to transduce fluorescence signatures from single chromophores that 
were electrokinetically transported through a series of tightly packed fluidic channels 
poised on poly(methylmethacrylate), PMMA and contained within the FoV of a laser 
detection system. The system was used to monitor biochemical reactions at the single-
molecule level in a continuous-flow format. Enhancement in sampling-throughput was 
demonstrated by constructing a high density fluidic network for parallel analysis of 
multiple biochemical assays. In another development, the ability to enhance single-
molecule sensitivity in a flow-based biochemical assay was investigated using a novel 
cyclic olefin copolymer (COC) planar waveguide embedded in PMMA and situated 
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orthogonal to multiple fluidic channels. This design allowed for fluorescence detection 
from multiple fluidic channels using evanescent excitation and a wide FoV fluorescence 
detection system for parallel readout. Results from these technologies were presented 
as well as their applications in drug discovery for increasing data production rates and 
quality.  
An approach toward monitoring the efficacy of therapeutic agents, which is 
important in clinical evaluation of drug potency in the drug discovery process, was also 
considered, by designing a microfluidic system with integrated conductivity sensor for 











I.1  Overview of the Drug Discovery Process 
Drug discovery research is an interdisciplinary endeavor, which has been 
increasingly propelled by chemistry and guided by pharmacology and the clinical 
sciences with deep impact from molecular biology and the genome sciences. The latter, 
combined with bioinformatics’ tools, allows us to clearly understand the genetic basis of 
diseases and to determine the most suitable sites of attack for future therapeutic 
agents. Thus, novel chemical structures with drug-like properties are generated through 
a discourse between biologists and chemists, with adequate understanding of biological 
structures and functions that define the biological mechanism of action.1,2 The advent of 
combinatorial chemistry has led to the generation of diverse sets of novel organic 
compounds (structure-based synthesis) to form large libraries of small molecules 
(combinatorial libraries),3-6 with each generated molecule being subjected to a series of 
purification and characterization processes followed by screening the entire library 
against a particular target to register potential drug candidates that can enter clinical 
trials.7 An overview of the drug discovery process is represented in Figure I.1. It takes  
10–15 years or more with an enormous financial investment (in excess of $500 million) 
to bring a new drug to the market.8 With advancements in scientific research, a number 
of new technologies that focus on improving the chances of discovering a new drug, 
which could also reduce the time line (discovery cycle) to 5–7 years, have been 
introduced. One key technology is centered on improving the efficiency of drug 





Figure I.1 Overview of the drug discovery pipeline showing the central role of high 
throughput screening (HTS) in the mechanism-based drug discovery process. Adapted 
with permission from Aherne et al.8 
 
I.2  High Throughput Screening and High Throughput Sample Processing 
The configuration of the screening platform in the drug discovery pipeline for high 
throughput processing is vital in maximizing the overall efficiency of the drug 
discovery process. This would allow for the ability to process multiple samples in a 
parallel fashion with a resultant reduction in the time requirement for the drug 
screening process. High throughput sample processing has also become the 
primary goal in other applications, such as molecular diagnostics and genome 
sequencing due to the large number of samples that must be interrogated. Obviously 
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from the illustration shown in Figure I.1, high throughput screening (HTS) plays a 
pivotal role in the drug discovery process with its utility spreading from the structure-
based design or analogue synthesis of compounds (combinatorial chemistry) via the 
‘hit to lead’ process to the generation of preclinical drug candidates.8 Thus, HTS has 
remained the essential starting point in the drug discovery process and has rapidly 
evolved into a highly efficient, robust, integrated and information-rich scientific 
discipline. Assay throughput has been continuously increased from the traditional 
96-well plates to higher density plate systems, for example, the use of microtiter 
plates with a 9,600-well configuration.9-12 The increasing demands to screen larger 
libraries of compounds against a number of therapeutic targets has incited 
technological advancements towards automated HTS. This trend was accompanied 
by miniaturization to reduce development and operating costs as well. While 
miniaturization facilitates assay automation and the realization of higher throughput 
formats through the use of parallel sample processing, it also reduces the amount of 
precious biological materials and chemical reagents used per assay. 
This advancement and need is being pursued through the use of microfabricated 
devices designed to perform continuous flow assays appropriate for HTS.13,14 For 
example, the potential of microfluidic systems for large-scale and high performance 
screening was demonstrated through the use of microfabricated microchannel array 
systems with automatic sample loading from microtiter plates to screen 96 samples 
in less than 90 s.15 The ultra-small sample volume associated with miniaturization 
was accompanied with detection challenges due to the ultra-small sampling volume 
and thus, required the use of sophisticated and high sensitivity detection techniques 
to readout the assay results. 
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I.3  Assay Readout Methods 
The development of homogeneous assays and the use of high sensitivity 
detection techniques have become increasingly important in the pursuit of  
automation, miniaturization, and high throughput in the drug screening process. It is 
highly required that miniaturized assays be properly designed with suitable readout 
methods to ensure robustness and reproducibility as well as statistical significance 
of the assay results.16  
Homogeneous screening assays are most frequently carried out using 
scintillation proximity assays (SPA) or fluorescence detection techniques depending 
on the particular type of target being investigated.17 Whilst most binding assays for 
cell surface receptors are often performed using SPA techniques, fluorescent-based 
methodologies that employ samples such as fluorogenic enzyme substrates, dye-
labeled substrates and fluorescent indicators for calcium and other ions are 
frequently used in enzyme and cell-based assays.17,18 Other methodologies based 
on phage-display techniques or heterogeneous assay formats, for example ELISA 
and agar plate assays19 have also been employed for screening. Given below will be 
a brief description of the SPA and fluorescence-based assays typically used in HTS. 
I.3.1 Scintillation Proximity Assay (SPA) 
The use of SPA techniques20,21 to measure high affinity binding 
interactions for cell surface receptors in HTS applications has largely replaced 
radio-labeled ligands and filtration assays due to the ability of SPA to eliminate 
separation steps. The technique is essentially based on measuring light emission 
from a surface bound scintillant as a function of binding interactions between a 
radio labeled ligand and surface immobilized receptor. Isotopes that produce low 
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energy emission particles are typically used to ensure that only surface bound 
ligands are detected.22-25  
I.3.2 Fluorescence-Based Techniques 
Fluorescence-based methodologies are becoming increasingly more 
popular for HTS applications due to the inherent sensitivity of fluorescence 
measurements and the industry-wide drift from the use of radioisotopes.  
Fluorescence techniques most widely used in homogeneous screening assays 
includes fluorescence resonance energy transfer (FRET), fluorescence 
polarization (FP), homogeneous time-resolved fluorescence (HTRF), and 
fluorescence correlation spectroscopy (FCS).26,27 
• Fluorescence Resonance Energy Transfer (FRET):  This is 
essentially a non-radiative energy transfer between donor and 
acceptor dye molecules with transfer efficiency being dependent on 
spatial criteria.28 It can be used to monitor enzymatic activities by 
measuring changes in observed fluorescence intensity resulting from 
substrate cleavage by the enzyme such that donor and acceptor drift 
apart.29-31  
• Fluorescence Polarization (FP): Changes in the rotational diffusion 
coefficient of small labeled probes upon binding to target molecules is 
measured using FP techniques.32 This technique provides rapid 
analysis of receptor-ligand binding interactions, enzyme-catalyzed 
hydrolysis of labeled substrates, protein-protein interactions and other 
binding assays of interest to HTS.33,34  
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• Homogeneous Time-Resolve Fluorescence (HTRF): Fluorescence 
signals from homogeneous samples are often hampered by 
background signal arising from sample matrix. One method of 
minimizing this problem is through the use of the time-resolved 
technique in which pulsed excitation sources and gated detectors are 
employed to allow the decay of background fluorescence before 
sampling the fluorescence signal of interest. HTRF utilize the 
advantage offered by europium crystates (i.e. long fluorescence life 
time and large stokes shift) to exploit energy transfer between an 
europium donor and suitable acceptors for screening applications.35,36  
• Fluorescence Correlation Spectroscopy (FCS): FCS has emerged 
as a suitable detection technique for HTS applications.37 In this 
technique, measurements are carried out using confocal optics to 
provide focused excitation light with the associated reduction in probe 
volume such that temporal fluctuations in signal as molecules diffuse in 
and out of the probe volume is observed. Autocorrelation analysis of 
time-dependent fluorescent signals generate information about the 
diffusion characteristics of the particles or molecules. This technique is 
also used for monitoring binding interactions since the binding of a 
fluorescence probe to another molecule results in a change in its 
diffusion coefficient. It is used in registering molecular events and has 
demonstrated potential for HTS applications.37,38  
Chemiluminescence39 and electrochemiluminescence40 have both shown 
detection sensitivities that compete with those of fluorescence and are suitable 
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for HTS applications.41 Electrochemiluminescence takes preeminence for HTS 
applications since reagents can be regenerated to sustain high photon flux rates 
over longer periods of time. 
I.4  Need for Single-Molecule Sensitivity 
Single molecule detection (SMD) represents the highest sensitivity in any 
analytical measurement and therefore possesses the ability to eliminate sample 
processing steps in multi-step assays as well as providing exquisite analytical 
sensitivity. For example, SMD provides the ability to detect biological 
components in their native concentrations without sample enrichment steps such 
as PCR amplification, and can record subtle changes in biochemical reaction 
profiles.  In addition, SMD reveals detailed information on molecular behavior 
such as complex fluctuations phenomena that are otherwise hidden within 
ensemble average techniques.42-45 These, together with the reduced assay time 
and short readout times associated with SMD, have given the technique 
immense recognition as a powerful analytical tool for biochemical assays 
especially in enhancing high throughput sample processing.26,46,47 The major 
advantages of SMD toward HTS are high statistical accuracy, even at 
measurement times of ~1 s, the ability to provide for the sensitivity demand of 
HTS with the pursuit of miniaturization,48-52 and most importantly, the low 
consumption of precious biological materials brought about by the ability to 
monitor reactions efficiently in ultra-small volumes, which provides a drastic 
reduction in assay cost.26,46 Typically, the technique employs ultra-small sample 
volumes with appropriate sample concentrations that allows sampling of exactly 
























Figure I.2 Illustration of fluorescence SMD with a tightly focused laser that generates 
femtoliter probe volumes such that the appropriate sample concentration is selected to 
keep single molecule occupancy at ~0.1. Only one molecule is sampled in the probe 
volume at any given time. 
 
I.5  Research Focus 
The overarching goal of my research area is the design of a microfluidic system 
for drug discovery (HTS) using near-IR fluorescence detection with single molecule 
sensitivity. A conceptual rendition of the target fluidic system with high throughput 
and automation capabilities is represented in Figure I.3. 
In this dissertation, I will focus on the development of ultra-sensitive detection 
systems for the rapid flow-based analysis of biological samples in a high throughput 
format. In one development, an ultrasensitive fluorescence detection system with a 
wide field-of-view (FoV) microscope was constructed to transduce fluorescence 




Figure I.3 Integrated fluidic system for performing HTS assays. The system will be 
configured on a 6” wafer and the wafer shown has 192 processors. The wafer consists 
of a stack of fluidic chips, with one chip used for containing the substrates and buffer 
reagents required for the HTS, a 96-element transfer chip to move drug candidates to 
the processor wafer and the HTS processor chip containing passive mixers, 2-phase 
flow generator and detector elements. The system will be operated in a 2-phase flow 
format with an inert separator liquid to significantly increase processing throughput.   
 
series of tightly packed fluidic channels poised on PMMA and contained within the 
FoV of the detection system. The system was used to monitor biochemical reactions 
at the single-molecule level in a continuous flow format. The potential of this system 
was expanded through the fabrication of a high density fluidic device (microchip) 
with individual reactors (vias) on the polymeric platform with suitability for HTS 
applications (drug discovery). In another development, the ability to enhance 
sensitivity in a flow-based biochemical assay was investigated using a novel 
  10
integrated embedded waveguide system. The embedded waveguide was used to 
effectively generate evanescence excitation across a series of fluidic channels to 
allow parallel excitation with subsequent detection of fluorescence signals from the 
fluidic channels. Finally, in another unrelated area, I focused on the development of 
a label-free technique using a conductivity sensor for on-chip enumeration of tumor 
cells as an approach to early disease diagnosis and monitoring efficacy of 
therapeutic agents (clinical evaluation of drug potency), which also form part of the 
drug discovery pipeline. 
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SINGLE-MOLECULE DETECTION: THE ULTIMATE SENSITIVITY IN ANALYTICAL 
MEASUREMENTS 
1.1 Introduction  
The scientific community has witnessed tremendous progress in the field of 
single-molecule research, which is continuously expanding due to technological 
advances and the promise of unparalleled capabilities to provide incredible molecular 
information that were hitherto hidden in conventional ensemble techniques.  Whilst 
standard ensemble methods generate results from large numbers of molecules, which 
correspond to their average properties, single-molecule detection (SMD) allows the 
interrogation of exactly one molecule in a complex matrix, and represents the ultimate 
detection limit defined by the inverse of Avogadro’s number (1.66 x 10 -24 or 1.66 
yoctomole). This allows for construction of actual distributions of complex phenomena, 
such as folding states of biomolecules, molecular configurations and stages of 
enzymatic cycles.1 Another benefit of single molecule studies is the ability to monitor 
molecular dynamics. For example, it can give detailed information about the stochastic 
motion of DNA enzymes or molecular motors in biological systems. In addition, single-
molecule detection could be a local reporter in the nanoenvironment such that small 
changes in its immediate surrounding can be clearly observed. These changes could be 
in the form of the presence of reactive functional groups, ions, atoms or electrostatic 
charges. Also, the ability to observe individual molecular events eliminates the need for 
synchronization, especially for molecules undergoing time-dependent processes such 
as triplet state crossing, thus enabling measurement of spectral shift or temporal 
fluctuations as a function of natural or induced perturbations in biological systems with 
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high efficiency.2,3 Finally, single-molecule methods eliminate sample preprocessing 
steps, for example, it allows measurement of native concentrations of cellular 
components, which are often present in few copies within biological cells.4-6 The science 
of single molecule spectroscopy spans several fields such as physics, chemistry and 
biology and thus has promoted excellent collaborations for making key advances in 
scientific research. 
 Early approaches to single-molecule detection included optical detection of 
multiply labeled single antibody molecules7 and detection of current from single ion 
channels in membranes.8 Subsequently, several exciting developments were made 
using various experimental approaches.9,10 These included, optical detection of single 
chromophores in solids at low temperature,11,12 detection of single fluorophores under 
biologically relevant conditions,13-15 imaging individual DNA molecules in water,16,17 and 
measurement of individual kinesin movements along a microtubule.18,19 This field of 
research has evolved through the last two decades to a status of a powerful and 
compelling technique for exploring molecular behavior at the nanoscale.20,21  
A  recent search using the PubMed data base (www.pubmed.gov) as conducted 
by Ha and coworkers22,23 showed a trend that appeared to be exponential with a 
doubling time of 2.2 years (see Figure 1.1) in terms of single-molecule research. This 
rapidly increasing research interest in single-molecule studies has motivated frequent 
breakthroughs in imaging and analyzing techniques, resulting in over 400 United States 
patents24 and consequently facilitating advances in biological sciences. For example, 
videos of the motion and biochemistry of macromolecular machines can now be 
generated at the single-molecule level, which are helpful in elucidating their mechanism 
and could potentially lead to the development of new drugs.24-27 
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Figure 1.1 Growth pattern of single molecule fluorescence research (appearing to be 
exponential with doubling time of 2.2 years). (a) Number of single-molecule publications 
per year. Data was obtained by searching the PUBMED data base with the keyword 
“single-molecule fluorescence”. Technical advances in FRET experiments are shown in 
gray; (b) technical advances in single-molecule tracking: translocation (purple), rotation 
(orange); (c) technical advances in live cells studies (green). Adopted with permision.23 
 
The two primary approaches for SMD are fluorescence and manipulation (force). 
Fluorescence techniques for SMD include FRET, polarization, lifetime, localization and 
intensity while manipulation includes optical and magnetic tweezers and atomic force 
microscopy (AFM). In this review and with regards to our research goal, particular 
attention will be given here to fluorescence techniques, however, a detailed discussion 
of manipulation methods can be found in selected papers.9,28-33  
1.2 Fluorescence Single-Molecule Detection 
With emerging technology, the utility of fluorescence spectroscopy in single 
molecule studies is becoming even more powerful due to the inherent sensitivity of 
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fluorescence detection.23  To be able to probe the molecule of interest, a laser beam is 
used to induce electronic transitions with the resulting optical absorption detected 
indirectly by monitoring the fluorescence emission.12 Appropriate dilution conditions are 
required to ensure that one molecule is resident in the probe volume (analysis volume) 
at any given time. This would mean for example, acquiring fluorescent signal from a 10-
15 liter volume of a 1.66 x 10-9 M (maximum concentration) solution. Obviously, 
fluorescence measurements from the molecule of interest is done in the presence of 
trillions of solvent molecules as well as noise from the detection system, thus 
techniques are employed to spectrally isolate the single-molecule fluorescence from 
unwanted signal emanating from its immediate vicinity. This is often achieved through 
the use of specially designed interference and/or Raman notch filters.11  
1.2.1 Basic Principle of Single-Molecule Fluorescence 
There are two basic requirements for realizing single-molecule sensitivity using 
fluorescence: (1) the use of ultra small probe volumes and (2) ensuring a signal-to-noise 
ratio (SNR) that is greater than unity (SNR >3 gives a statistical result with 99.7% 
certainty) for the single-molecule signal. In most fluorescence-based single-molecule 
experiments, the small probe volume requirement is obtained by focusing the laser 
beam to a diffraction limited spot, however,  appropriate concentrations of the analyte 
molecule of interest contained in an ultrapure host matrix must also be selected based 
on Avogadro’s criterion  to keep molecular occupancy lower than unity in the probe 
volume. This is important to avoid double occupancy at a reasonable sampling time 
such that any signal registered is indeed from a single molecule. The required SNR is 
obtained through adequate suppression of background signals, which mainly originate 
from undesirable fluorescent impurity in the sample, Raman scattering from the solvent, 
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Rayleigh scattered radiation at the pumping wavelength and residual fluorescence from 
the optical system.34 The challenge therefore is to increase the signal size from the 
single molecule hidden in its host matrix as much as possible. This is achieved, in 
addition to using a small focal volume by using fluorophores with large absorption cross 
sections, high photostabilities and a weak tendency for triplet state transitions. Also, the 
pumping laser must be operated below optical saturation of the molecular absorption. 
Although the number of photons emitted by a single molecule per second is much 
smaller compared to the number of photons per second from the incident laser beam, 
the Stokes’ shift associated with the molecular absorption phenomena makes it possible 
to carefully isolate the weak fluorescence from a single molecule. Illustration of the 
prominent features in the energy level diagram of single-molecule fluorescence is 
shown in Figure 1.2. Typically, the ground state (S0) molecule absorbs energy from the 
pumping laser to undergo an electronic transition to a higher electronic energy level 
(S1), which quickly relaxes to the lowest energy level of the excited state (S1) from which 
fluorescence photons are emitted. Energy losses due to vibrational relaxation causes 
red-shifts in the emission wavelength (Stokes shift). The molecule can undergo several 
absorption-emission cycles prior to photobleaching. It is also important to note that there 
is a finite probability for intersystem crossing (ISC) into the triplet states, which often 
results in fluorescence intermittency or photoblinking in single-molecule experiments 
depending on the properties of the fluorophore and experimental conditions.35,36 
1.2.2 Fluorophore Consideration for SMD 
Fluorophores can be referred to as molecular spies in single molecule 
experiments with information feedback channels occurring as fluorescence. Thus, when 
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attached to biological molecules, they reveal information that depicts the molecular 
 
Figure 1.2 Energy level diagram for single molecule spectroscopy showing the ground 
singlet state (S0), first excited state (S1), lowest triplet state (T1), and other intermediate 
states. Single molecules can be recycled many times through this scheme to generate 
millions of photons. Adopted with permission.20 
 
processes in the vicinity of the host molecule. However, single dye molecules emit 
limited amounts of fluorescence, which must be maximized to facilitate a clear 
observation of processes when placed in its nanoenvironment. Consequently, an ideal 
fluorophore is required for a successful single molecule experiment. Fluorophores 
should stay photoactive under intense illumination, possess high absorption cross-
sections and fluorescence quantum yields, does not modify the properties of the host 
molecule and should show steady emission intensity. Typical fluorescent molecules 
used for single molecule studies originate from the general classes of laser dyes used in 
biological fluorescent labeling. These include rhodamines, cyanines, oxazines, terrylene 
or perylene diimide.37-39 In addition, classes of genetically expressed proteins like green 
fluorescent protein (GFP) have been employed for single-molecule fluorescence 
studies.40,41 In the cyanine family, Cy3 and Cy5 are extensively used either individually 
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or as a FRET pair.42-44 These dyes have high photostability and good fluorescence 
quantum yields.45 Other popular fluorophore includes Cy5.5 and Cy7. In the rhodamine 
family, tetramethylrhodamine,46,47 rhodamine 6G, Texas Red, and bis-sulfonerhodamine 
have been used. Other fluorophores of interest includes Alexa dyes23 and some new 
classes of single molecule fluorophores found among molecules originally optimized for 
non-linear optics.48 In addition, some proteins are naturally fluorescent with the 
presence of one or many fluorophores serving as a co-factor, and have been used to 
obtain useful information for single-molecule interrogation, for example in the cases of 
flavoenzymes49,50 and complexes containing bacteriochlorophyll molecules.51 Novel 
fluorescent dyes, such as the phthalocyanine derivatives,52 have been synthesized and 
used for molecular single molecule studies as well. These dyes have been 
characterized with self quenching, resulting from aggregation and thus eliminate the 
need for a separate quencher in RET-based experiments.53   
1.2.3 Physical Effects that Limit Fluorescence Emission from Single Molecules 
The major physical effect related to single-molecule fluorescence is 
photobleaching, which is an irreversible process that causes molecules to eventually 
change to another, non-fluorescent form. This is true for almost all molecules in 
aqueous solution and typically occurs after emission of specific number of photons. 
Under favorable conditions, individual molecules can emit on the average 105 – 106 
fluorescence photons before photobleaching. Although, there are many factors 
responsible for photobleaching, in most cases, it is mainly due to photo-oxidation. Thus, 
methods such as flooding the system with inert gases,54 operating the detection system 
in vacuum,55  and incorporation of enzymatic oxygen scavengers56,57  to reduce the 
presence of molecular oxygen can help to reduce this effect. 
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 Another physical effect is optical saturation. The amount of photons emitted per 
second scales linearly with the laser power as long as the saturation point is not 
exceeded.58 However at optical saturation, the absorption cross section from the 
molecule decreases such that further increases in laser power only generate more 
background with no increase in the amount of emitted photons. The net effect of this is 
a decrease in the SNR for the fluorescence measurement. It is also important to note 
that the scattering signal is always linear with laser power; therefore, appropriate 
conditions are required to balance the relationship between these factors in order to 
maximize the fluorescence signal from single molecules. 
1.2.4 The War Against Background Signal 
A major challenge in designing single-molecule experiments is the ability to 
conquer or reduce background signal. This is because almost all single-molecule 
experiments are background limited. As noted previously, background signal may arise 
as a result of residual fluorescence from the solvent system used, scattered radiations, 
and/or residual emission from excitation sources that extend into the spectral range for 
fluorescence detection especially when a diode laser is employed as the excitation 
source.20  These sources of background, although critical, can be minimized by using 
multiple filters and high quality optical components. Other sources, such as elastic 
Rayleigh scattering from the sample itself as well as from its immediate environment 
(e.g. backscattering from sample container) can be reduced through the use of 
ultraclean, scratch-free substrates of the highest quality and interference filters. 
Unfortunately, red-shifted Raman scattering from the host matrix and residual 
fluorescence from impurities in the sample or host matrix provide a greater problem. 
Both are proportional to the size of the probe volume, and though a logical step is to 
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reduce the probe volume size as much as possible, impurities or molecular components 
of the host matrix can generate very strong residual fluorescence. This problem is more 
pronounced when working in the blue or ultra-violet spectral regions. It is therefore 
paramount to use ultrapure solvents for samples to be interrogated. A prediction of the 
possible emission wavelength of an unavoidable biological matrix may be helpful in 
selecting the right fluorophore and optical filtering systems that will minimized the effect 
especially when working in the UV region. Another method of overcoming this problem 
is to work in the near infra-red spectral region where interference from unwanted 
emissions is highly minimal. 
1.3 Techniques: Instrumentation for SMD 
Typical optical instruments used for single-molecule measurements are based on 
three major experimental formats. These are confocal, scanning and wide-field 
methods.59 Essentially, the optical configuration for each of these methods is aimed at 
limiting the observed volume and carefully isolating the small number of photons 
emitted by a single molecule. All emerging single molecule fluorescence techniques are 
based on these methods which are considered in detail below. 
1.3.1 Confocal Method for SMD 
The observation volume in fluorescence measurements is drastically reduced 
through the use of confocal optics, which allow for rejection of signal from above and 
below the focal plane of a tightly focused excitation source. Figure 1.3a shows a 
simplified schematic of a typical instrument used for confocal fluorescence detection. 
Although this can also be configured in a trans-illumination format, the epi-fluorescence 
(epi-illumination) format is the most common optical design for confocal microscopy and 
this format has been described in detail in many reports.20,60-63 Essentially, a collimated 
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laser beam is directed through a high numerical aperture (NA) microscope objective 
using a dichroic beam splitter. This results in the generation of a focused diffraction 
limited laser spot at the sample plane (see Figure 1.3b). All fluorophores within the laser 
spot are excited and fluorescence emission as well as backscattered light from the 
substrate and Raman scattering from the sample matrix are collected by the same 
microscope objective, passed through the dichroic beam splitter and subsequently 
through other appropriate emission filters to isolate the fluorescence emission of 
interest, which is then focused on the detector (usually a single element detector such 
as SPAD) through a pinhole aperture located on the optical plane of the emitted 
fluorescence. The pinhole serves as a spatial filter that rejects out-of-focus light. This is 
called the confocal advantage. It is important to note that the excitation volume is 
defined by the size of the laser spot, therefore the use of high NA microscope 
objectives, which generate small laser spot-sizes, helps in minimizing the observed 
volume to improve the SNR in SMD by both increasing the signal (high collection 
efficiency) and reducing background. A careful selection of the proper size pinhole is 
very important in optimizing and isolating the single molecule fluorescence signal. 
Although smaller pinholes are difficult to align, they give superior axial resolution. 
Excellent treatment of pinhole selection has been given by Corle et al.64 The spatial size   
of the fluorescence at the pinhole is simply determined by the diameter of the diffraction 
limited laser spot multiplied by the magnification of the microscope objective. For 
example, the spatial spread of the fluorescence collected from a laser spot size of 3 µm  
using a 40x microscope objective would be ~120 µm. In this case, a pinhole with a 
diameter of 80 µm will reduce the amount of fluorescence transmitted to the detector but 
will give a better axial resolution. On the contrary, a pinhole with a diameter of 150 µm 
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will transmit more fluorescence to the detector, but will generate poorly resolved signal 
and high background. Therefore, a perfect correlation of this factor with the size of the 
pinhole allows for better fluorescence transmission through the confocal aperture. 
(a) 
        
Figure 1.3.  (a) A simplified schematic of confocal optics for single-molecule detection. 
Adapted with permission from Tinnefeld  et al.65 (b) A pictorial representation of the 
focused laser spot produced by a confocal set up. The red spot represents the focal 
volume.  
 
1.3.2 Scanning Methods 
The availability of highly accurate motorized stages that provide resolution down 
to molecular sizes has created opportunities for fluorescence image acquisition using a 
single element detector. The fluorescence image in this case is a reconstructed image 
obtained by raster scanning the sample. There are basically two scanning methods 
used for SMD. These are; confocal microscopy that utilize the confocal advantage (see 
above) and near-field scanning optical microscopy (NSOM), which creates a laser spot 
smaller than the diffraction limit.  
(b) 
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In confocal microscopy (confocal imaging), the instrumentation is similar to that 
shown in Figure 1.3a except that in this case, a computer controlled motorized sample 
stage is employed to facilitate the scanning. A typical single molecule image of a green 
fluorescence protein (GFP) mutant 10c collected using confocal optics and stage 
scanning is shown in Figure 1.4. The size of the fluorescence spots are about 500 nm in 
diameter, which is determined by the optical resolution and not the size of the molecule. 
         
 
Figure 1.4 Fluorescence image of a single GFP mutant 10c collected using confocal 
scanning microscopy. Fluorescent spots are about 500 nm for each GFP molecule. 
Adopted with permission. 66 
 
NSOM is based on a simple principle.67,68  In this case, a highly localize 
excitation is obtained using an optical fiber to create a relatively smaller laser spot. The 
laser spot is generated from a narrow aperture produced by a modified optical fiber (see 
Figure 1.5a). In early studies using NSOM, a single-mode optical fiber was heated and 
pulled until it broke, forming a narrow tip that was much smaller than the original fiber 
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core.69 The sides of the fiber are then coated with aluminum to form a waveguide for the 
light travelling through the optical fiber with a tiny aperture, which is typically 70 - 80 nm 
in diameter.70 Laser light is focused to enter the larger distal end of the fiber while the tip 
of the fiber is positioned near the sample (~5 nm from the surface) using components 
similar to those developed for probe techniques, such as atomic force microscopy 
(AFM). While the fiber is located at a known distance from the sample, the stage is 
scanned to create fluorescence images at the far-field end using traditional optics and a 
single element detector. In this format, only a small region of the sample is excited, 
thereby eliminating the need for a confocal aperture. Figure 1.5b shows a typical NSOM 
image of single molecules of the dye, oxazine 720, in PMMA with fluorescent spots that 
are below 100 nm in diameter. The spatial resolution in this image is not limited by the 
optical resolution set by diffraction, but is determined by the diameter of the probing 
fiber when in the near field with respect to the sample. NSOM has been used to reveal 
heterogeneity among spectral properties of a single emitter as a function of time71 and 
also to measure single-molecule fluorescence lifetimes.72 The major advantage of 
NSOM includes the reduced sample volume offered by the extremely reduced laser 
spot size, which generates low background counts and immediate orientation 
information. Also, by monitoring the position of the scanned fiber tip, topographical 
information can be obtained with the fluorescence image.20 However, this technique is 
limited to flat samples because of the brittle nature of the fiber tip, which is susceptible 
to breakage. Also, imaging single molecules far from the surface is impossible due to 
the fact that the near field regime quickly disappears or disperses in the z-direction, thus 
limiting the application of NSOM in many biological systems, such as the interior of a 
cell. In addition, it is difficult to consistently make fibers with the same aperture size. 
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Nonetheless, a potential solution to some of these limitations is the use of apertureless 
NSOM techniques, which utilize ultrasharp tips as an antenna to localize the excitation 


















Figure 1.5  (a) Schematic representation of instrumentation used for NSOM. Adapted 
with permission.65 (b) Single molecule image of Oxazine 720 molecules acquired with 
NSOM, adapted with permission.74 
 
1.3.3 Wide-Field Methods 
Similar to traditional microscopy, wide-field methods for SMD utilize an excitation 
source (usually a laser) to illuminate an area several microns in diameter. Fluorescence 
emission from single molecules within the illuminated area are properly isolated and 




performed in this fashion provide two major advantages: (a) simultaneous observation 
of several individual chromophores and (b) the ability to monitor individual 
chromophores at near video frame rates to allow for the observation of real time 
translation of single molecules. However, wide field microscopy methods have a primary 
limitation that stems from the fact that the maximum frame acquisition rates for CCD 
cameras is much slower than the response time of single element detectors. This 
limitation has been greatly curtailed with technology advancements in CCD designs, 
which have made available ultrasensitive frame transfer electron multiplying CCDs 
(EMCCDs) capable of generating amplified fluorescence signal through their intrinsic 
signal cascade characteristics. Although, a large region of the sample is imaged onto 
the detector’s active area, the ability to determine single molecule position is controlled 
by the size of the CCD pixels and the total magnification of the optical system. Spatial 
resolution is enhanced by dispersing the image over a greater number of CCD pixels by 
using a CCD with smaller pixel sizes and a large pixel array. Because single molecule 
photobleaching limits the total number of detected photons and one needs to collect 
sufficient numbers of photons per pixel for a given integration time to be able to 
maintain a reasonable SNR, appropriate magnification must be carefully selected in 
designing the optics for wide-field imaging of single molecules. Although, CCD image 
signal processing operations, such as binning, can assist in improving SNR when high 
magnification and high NA microscope objectives are used, it does so at the expense of 
spatial resolution.  
There are basically two techniques for wide-field single molecule studies; these 
are epi-fluorescence and total-internal reflection (TIR) microscopy. Implementations of 
both techniques are discussed below. 
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1.3.3.1 Epi-Fluorescence Microscopy 
Epi-fluorescence microscopy has been used for many years for biological 
applications and was first applied to room temperature single-molecule experiments in 
studying a biomolecular motor.42 A simplified schematic of the instrumentation used for 
epi-fluorescence microscopy is shown in Figure 1.6. An approach for achieving wide 
area illumination (excitation) is to use a non-collimated excitation beam, which is 
focused on the back aperture of the microscope objective. The result is a collimated 
output from the front aperture of the microscope objective with the field of illumination 
determined by the size of the microscope’s aperture. An easy method of accomplishing 
this is to use a lens with the appropriate focal length situated within the optical path of 
the excitation light. A high NA microscope objective is usually employed to maximize the 
detected fluorescence. Also, the flatness of field for the objective is an important 
consideration in wide-field imaging, especially in situations that require careful 
quantification of distance molecules across the image plane. Consequently, microscope 
objectives with the highest flatness of field, such as those designated as “Plan Apo” or 
“Plan Fluor” are typically used for wide-field imaging. Furthermore, it is very important 
for the microscope objective to have very low residual fluorescence artifacts, especially 
in the region of interest. The resulting single-molecule fluorescence is collected with the 
same objective (epi-fluorescence) and carefully isolated using the appropriate optical 
filters prior to being focused onto the CCD camera. Wide-field SMD has been applied in 
the study of the motion of critical structures in single cell membranes75 and has also 
been used to explore diffusion of single molecules of transmembrane proteins 
embedded in live cells.76 Recently, the ability of wide-field SMD to monitor biochemical 
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reactions was demonstrated in studying thermal denaturation and the melting profile of 
labeled DNA molecules in a FRET assay.77  
 
 
Figure 1.6 Schematic of epi-fluorescence optics; objective (O), dichroic filter (D), 
emission filter (F).  Adopted with permission.20 
 
1.3.3.2 Total-Internal Reflection (TIR) Fluorescence Microscopy 
TIR fluorescence measurements utilize the exponential decay of an evanescent 
field generated at a high-index to low-index boundary when light is incident on a low-
index medium from a high index material at an angle greater than the critical angle (the 
angle at which total-internal reflection occurs). The decaying evanescent field 
penetrates into the low-index medium to a small distance often referred to as the 
penetration depth. This distance is typically ~150 nm for green laser excitation, which 
implies that only fluorophores that are sufficiently close to the boundary will be excited 
while those further away in the bulk sample will not be excited. As a result, only a very 
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small volume of the sample is observed. Implementation of TIR fluorescence for SMD 
can be achieved using a prism that is coupled to a microscope cover glass or a thin 
glass substrate (or any other suitable substrate of high refractive index) using index 
matching oil. TIR is achieved when the laser beam is launched into the prism above the 
critical angle, which generates an evanescent field at the interface.78 A schematic 
drawing of a prism-type TIR set-up used for imaging single dyes79 and single GFPs80 is 
shown in Figure 1.7a. 
 Another method by which TIR is implemented for SMD is to couple the input 
laser beam through the edge of a high NA microscope objective such that illumination 
occurs around the sides of the glass-water interface, where the launch angle is above 
the critical angle. This creates an evanescent field that excites a thin plane of the 
sample near the interface. This method was first implemented by Funatsu et al.42 and is 
called through the objective TIR.81 This is represented in Figure 1.7b.  
An optical fiber has also been used to generate evanescent field excitation 
through TIR. In this case, a section of the core of the optical fiber is exposed to the 
fluorophore such that when light is coupled into the optical fiber, the evanescence wave 
field generated on the core surface is used to excite the fluorophore in close proximity to 
the fiber surface. A simplified set up for this technique is represented using the 
schematic diagram shown in Figure 1.7c.82   
 A typical image acquired using TIR optics is shown in Figure 1.8. This image was 
obtained using the prism-type TIR configuration. Note also that this is one method by 
which single molecule fluorescence data is displayed for easy comparison of the relative 
intensities of individual molecules. Due to the low background of this image, information, 
such as molecular diffusion, can easily be extracted. 
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Figure 1.7 (a) Schematic diagram of a prism-type TIR experiment. Adapted with 
permission.22 (b) Schematic diagram of an objective-type TIR; adapted with 
permission.20 (c) Excitation through an optical fiber; adapted with permission.82  
 
1.3.4 Detectors for SMD 
The ability to detect single-molecule fluorescence depends not only on the optical 
design of the detection system but also on the efficiency of the readout device. Such 




Figure 1.8 A typical single molecule image of GFP mutant T203Y acquired with a CCD 
using TIR fluorescence; adapted with permission.66 
 
able to register fluorescence signals from single molecules. Thus, an important 
consideration in designing the instrumentation for single molecule experiments is the 
selection of an appropriate readout device with a matching capability for the particular 
single-molecule experiment format. Detectors for SMD are classified into two groups: 
single element detectors and two-dimensional array detectors. Each of these classes of 
detectors has unique capabilities and characteristics for different experimental 
approaches. While single element detectors are mainly used for point-by-point 
fluorescence detection (e.g. in confocal methods and scanning methods), two-
dimensional array detectors are used for wide-field microscopy. 
1.3.4.1 Single Element Detectors 
Early single-molecule experiments utilized photomultiplier tubes (PMTs) to 
register fluorescence from single molecules diffusing through a tightly focused laser 
spot.13 PMTs have large active areas (photocathode), which can be greater than a 
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square centimeter, and are generally able to multiply single photon events by a million-
fold while at the same time offering suitable temporal response with low dark noise 
levels when cooled. However, they typically have low quantum efficiencies (about 20%), 
which further decreases at longer wavelengths thus limiting their use in SMD for 
extended-red fluorophores. Also PMTs require high voltages to operate and have 
several pieces of electronic components for single photon counting, which makes the 
design a little complex. 
A more simple and generally preferred detector for single-molecule fluorescence 
is single photon avalanche photodiodes (SPADs), which offer several advantages 
compared to PMTs. SPADs are available in small integrated packages with on-board 
amplification and requires only ~5 V to operate. SPADs have quantum efficiencies 
greater than 60% in the visible region of the electromagnetic spectrum with up to 90% in 
the near-infrared (NIR). Generally with SPADs, a detected photon is converted to a 
digital output pulse, which is counted using a computer-based digital acquisition 
board.83 SPADs also have low dark count rates (25 – 100 cps) comparable to the best 
cooled PMT. The only disadvantage of SPADs compared to PMTs is the small active 
area of the SPAD (~200 µm in diameter), which creates a challenge in the design of a 
typical fluorometer since most of the collected photons could fall on the non-active 
regions of the SPAD and thus will not be detected. However, this limitation becomes an 
advantage in confocal imaging where the small active area can be used as a confocal 
aperture to improve the signal quality. 
1.3.4.2 Two-Dimensional Array Detectors 
Wide-field methods for SMD employ array detectors, such as microchannel 
plates or CCDs. The microchannel plate detector is a large area PMT that is configured 
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to register fluorescence signal in two dimensional x-y formats. Although this detector 
can provide fast timing information, it has a low quantum efficiency, comparable to that 
of a conventional PMT. The detector of choice for wide-field microscopy is the CCD, 
due to its intrinsically high single photon detection efficiency with low read noise.  A 
CCD contains an array of pixels, each of which acts like an individual detector84 and 
makes it possible to register multiple isolated fluorescent signals on a single CCD chip. 
Back-illuminated CCD cameras have been used in astronomy and spectroscopy. 
This type of CCD camera has high quantum efficiency ranging from 70 – 80% in the red 
and infrared regions and they are built with liquid nitrogen cooling to operate at ~120oC 
to reduce dark counts down to the level of 1 electron/pixel/h. However, these detectors 
are limited by their characteristic read noise (~20 electrons for each analog-to-digital 
conversion) and operate with low speed. Consequently, they are best used in situations 
that allow long signal averaging times. 
Another generation of CCD is the intensified frame transfer CCD cameras, which 
are designed with optical integration using a photocathode, fiber bundle, microchannel 
plate, phosphor screen, and Si CCD chip. Photons are first detected by the 
photocathode, and the emitted electrons are amplified in the microchannel plate that is 
coupled to the photocathode using a fiber bundle. Subsequently, the phosphor screen 
generates photons from the amplified electrons, which are converted back to electrons 
by a front-illuminated Si CCD detector. A fast analog-to-digital converter (ADC) is used 
to generate digital numbers from the electrons in each CCD well. The advantage of this 
design is the ability to multiply the detected photoelectrons prior to readout and 
continuous readout provided by the frame-transfer mode. In the frame transfer mode, 
the entire frame of the CCD is transferred to a non-photosensitive area following each 
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exposure. Also the use of a fast ADC allows these detectors to operate at high frame 
rates (near video frame rates) without sacrificing single photon detection efficiencies. 
While these detectors provide for high speed imaging, they are characterized by a low 
quantum efficiency, excess noise from the multiplication process and non-uniform gain 
over the microchannel plate. 
The back-illuminated frame-transfer CCD camera is another class of detectors 
designed with fast ADC capabilities that operate without large increases in read noise. 
This design provides for uniform sensitivity from pixel-to-pixel and retains the high 
quantum efficiency of back-illuminated CCDs.84  
Further developments in CCD technology have recently made available ultra-
sensitive frame-transfer CCDs designed with on-chip multiplication gain. In this design, 
the last row of the CCD wells is connected to a series of additional wells such that 
secondary emission is generated as the electrons are passed from well-to-well. This 
can result in a multiplication gain of ~1000 depending on the number of pixels in the 
serial register. This detector is finding wide spread applications in SMD with a major 
advantage of signal amplification, reduced read noise and continuous imaging at video 
frame rates. 
1.3.5 SMD Data Analysis 
Single-molecule fluorescence is governed by photon statistical models,85-88 which 
allows for the derivation of experimentally measurable characteristics of interest such as 
the autocorrelation function or photon burst distribution.89  
SMD experiments are usually characterized by low SNR, thus creating a challenge 
in the ability to clearly distinguish background noise from single-molecule signal as well 
as distinguishing different molecules by their emitted photons. The autocorrelation 
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function has been shown to be a useful tool for dissecting the average motion of small 
molecules.13,89 It has also been demonstrated as a sensitive indicator of fluorescence 
signal produced by individual molecules as they traverse through a focused laser 
beam.13,14 For a data set d(t) consisting of N consecutive values of the number of 
photons detected in a specific time interval (ז), the digital autocorrelation function A(ז) is 
given by:13,14  
                                    (1.1) 
Where d(t + ז) represents the data point (value) at time t + ז. A plot of the function A (ז) 
for a given experimental data set would generate a peak, which is easily distinguishable 
from background signals. The autocorrelation peak is an indicator of the presence of 
molecular species in the probe volume. In the absence of emitting species in probe 
volume, the peak disappears.  This is because the random noise of the background is 
not recognized by the autocorrelation function. The width of the autocorrelation peak is 
a measure of the time a dye molecule stays in the probe volume (molecular transit 
time). It can be used to discriminate different molecular species based on their transit 
time. The autocorrelation function will indicate that a high sensitivity (molecular level) is 
achieved in the experimental measurement. However, this type of analysis is not able to 
identify single molecules as they migrate through the excitation volume.  
A more quantitative approach for identifying the passage of individual molecules 
through an illuminated volume element is the use of the weighted quadratic sum 
(WQS);13,14,90  
                            (1.2) 
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where k is the approximate time interval representing the lower limit of the molecular 
transit time or the average photobleaching lifetime of the dye molecule, and ω(ז) is a 
weighting function chosen to best distinguish the single molecule signal from 
background fluctuations. Usually ω(ז) is chosen to compensate for the time interval 
between when the molecules approach the excitation volume and the photobleaching 
lifetime of the molecule (sometimes, ω(ז) represents a Gaussian). For the WQS, S(t) will 
have a sharp maximum whenever emitting dye molecules flow through the laser such 
that when a threshold value Sth is set, the data set is sufficiently filtered from 
background interference. In other words, a signal S can be clearly identified as a single 
molecule signal when S(t) > Sth . This quantitative information can be used to calculate 
the detection efficiency (DE) of the detection system by using;  
    DE = Md/Men                                  (1.3) 
where Md is the number of molecules detected and Men is the number of molecules that 
enter the detection volume. 
 The maximum-likelihood criterion (MLC) is another tool, which can be used to 
process single-molecule data.90 This is based on a probability distribution of background 
noise and single-molecule signal.91 For a given data set N, the probability that N 
represents single-molecule events (Pmol) and the probability that N represents 
background fluctuations (Pnoise) both are calculated and fitted into the MLC function 
(M):90  
 
                                    (1.4) 
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M > 0 = molecule present 
M < 0 = no molecule present 
The MLC simply states that the process with the highest probability is the most likely. 
1.3.6 High Throughput SMD 
The advent of wide-field imaging and improved technology in CCD design (see 
section 1.3.3) has created an opportunity for throughput enhancement in single 
molecule experiments. This allows for the simultaneous study of several surface bound 
single molecules92 and monitoring of molecular motion in solution.93,94 Also, 
advancements in micro-total analysis systems (µ-TAS)95 has enabled parallelization of 
SMD experiments, which has allowed maximizing throughput via parallel multi-sample 
processing in short analysis times. 
1.4 Merging Microfluidics with SMD 
Microfluidics can be defined as the technology of systems capable of processing 
and manipulating minute amounts of fluid (liquid samples) using micrometer-scale 
channels. These systems or devices consist of microfabricated structures, which can be 
designed to produce diagnostically useful systems (e.g micro-total analysis system, µ-
TAS) for such applications as point-of-care (POC) measurements.95-98 There has been a 
rapid growth and wide spread applications of microfluidic technology since the 
conceptualization of miniaturized chemical analysis systems in the early 1990s.99,100 
Presently, it is adopted in various fields of applied research, such as DNA 
sequencing,101,102 immunoassays,103 protein analyses,104 and clinical diagnostics.105 
Microfluidic-based systems possess unique advantages, such as sample 
miniaturization, reductions in reagent consumption, short analysis times and the ability 
to integrate several processing steps into a single system, which simplifies routine 
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operations and also eliminates sample cross contamination. In addition, these devices 
are viable platforms for parallel processing of multiple assays (High Throughput 
Screening, HTS) due to the inherent ability to generate multiple fluidic processors over 
small footprints suitable for optical imaging.106-108 Other benefits include the ability to 
automate fluid handling and drastically reduce assay cost.  
While microfluidic channels provide the interface required to handle small sample 
volumes, SMD allows for the localization, counting, and identification of individual 
molecules present in the small volume. Thus, by merging microfluidic technology with 
SMD, the optimal requirement for the analysis and manipulation of samples on a single-
molecule scale can be achieved; such merger would facilitate system integration and 
automation suitable for increasing throughput in biochemical screening such as HTS in 
drug discovery.108 In more specific terms, SMD in combination with microfluidics offers 
new tools for research; First, single-molecule analysis permits a reduction in the number 
of molecules needed per assay, thus the total sample volume and the sample 
concentration can be drastically decreased. This is particularly important when dealing 
with such systems as biological cells that have few copies of target analytes. Second, 
the identification of single molecules greatly reduces the time required for data 
acquisition; consequently miniaturized samples are analyzed with increased speed and 
high statistical accuracy. Third, mixtures of analytes can be analyzed in a flow-based 
format with higher molecular detection efficiency by employing distinct identification tags 
(multiplex single-molecule detection). Fourth, the ability to carry out multiple assays in 
parallel with single-molecule sensitivity (high throughput SMD). 
Silicon and glass have been traditionally employed for creating microfluidic 
devices109, 110 based on fabrication techniques developed in the microelectronics sector. 
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Successful fabrication on these substrates has been accomplished using several 
methods such as lithography, plasma etching or reactive-ion etching techniques.111,112 
The attractiveness of glass and quartz as classic materials for microfluidic applications 
includes their well-defined surface chemistry, good electro-osmotic properties and 
excellent optical properties, which are suitable for fluorescence measurements. 
However, the fabrication modalities are quite challenging and relatively expensive. This 
result into a search for alternative materials, that are more conducive to large-scale 
production. 
1.4.1 Polymers as Fluidic Chip Substrate for SMD 
Polymer materials offer important advantages in microfluidic device production. 
This is essentially due to their wide range of material properties, which can be selected 
for diverse applications. In addition, they are generally low-cost materials with good 
processibility requiring simple fabrication procedures to make devices allowing for the 
inexpensive replication of microstructures and the mass production of disposable 
microchips.113 However, many polymers display poor optical properties that may not be 
conducive to ultra-sensitive fluorescence measurements required for SMD and thus, a 
careful selection of a suitable polymer for microfluidic construction must be made based 
on their properties to ensure high performance for the intended application.113-116 For 
SMD, properties that are of fundamental importance include the optical transparency, 
autofluorescence levels, biocompatibility and chemical resistance. Other properties 
such as the glass transition temperature, machinability, tensile strength and thermal 
conductivity are important in selecting the appropriate material. A compilation of 
physical and chemical properties of the most widely used polymers for microfluidics 
applications is shown in Table 1.1 (adopted from Becker et al. 115).  
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1.4.2 Microfabrication Techniques 
Fabrication of the desired fluidic structures on polymers for SMD can be 
achieved by several methods including lithography, UV-laser ablation, hot embossing, 
injection molding, direct micromilling, or soft lithography. Detailed descriptions of these 
methods can be found in selected reviews.117-120 However, a brief description of LiGA is 
given below;121,122 
1.4.2.1 LiGA 
A common approach for large –scale production of microfluidic devices using a 
polymer substrate is LiGA; a German acronym for lithography, electroplating and 
molding. This process is normally employed to fabricate high quality mold inserts for 
mass production of polymer parts (microfluidic devices). It employs either a synchrotron 
source (X-ray LiGA) or UV light (UV-LiGA) as appropriate for a particular microfluidic 
design.123 In X-ray LiGA,124 an X-ray sensitive resist, such as PMMA, is coated on a 
plating base (e.g. stainless steel), which is then exposed to X-rays to form 
microstructures using an appropriate X-ray mask that has the defined pattern. The 
exposed photoresist is then removed in a developing step using a GG developer (a 
mixture of water, 2-(2-butoxyethoxy)ethanol, tetrahydro-1,4-oxazine and 2-
aminoethanol),125 which is a solvent that dissolves the exposed portion of the resist. 
Following this step is an electroplating process that fills up the voids between the 
polymeric features with metal (usually Ni), which is deposited over the top of the 
patterned resist to a thickness of ~5 mm to obtain a metal mold.  A schematic of the 
LiGA processing steps using X-ray photopatterning is shown in Figure 1.9. After the 

































































master, which can be used to replicate polymer microstructures repeatedly through 
injection molding or hot embossing. 
UV-LiGA operates with the same principle except that a UV light source is used 
instead of X-rays.126,127 This approach has been used to produce high aspect ratio 
patterns using SU-8 as the resist.128 
1.4.2.2 Hot Embossing 
This is a replication technology used to transfer fluidic patterns from a mold 
master into the required polymer substrate.129,130 The pattern on the mold master can be 
made either by micromachining131,132 or by a lithography-based approach such as LiGA. 
Hot embossing is done in three steps; first, the suitable polymer material is placed 
between two metal plates (one contains the mold master) and heated to above its glass 
transition temperature (Tg). Second, a controlled force is then applied onto the soften 
polymer by pressing the heated mold master under vacuum for few minutes. Third, the 
metal plate and polymer substrate are cooled below the Tg of the polymer prior to the 
withdrawal of the metal plates to form the desired pattern in the polymer. This technique 
is very simple and cost effective. It has a fast processing time of ~5 mins and can be 
used to produce thousands of parts from a single mold master. Examples of parts 
fabricated using this technology are shown in Figure 1.9 
1.4.2.3 Thermal Annealing 
Following the transfer of the fluidic pattern into the polymer substrate as 
described above, the next step is the creation of the fluidic channels. This is mostly 
done by thermal annealing. In this process, a thin polymer sheet, often referred to as 
cover sheet, which should be of the same (or similar) material properties (especially the 
glass transition temperature, Tg) as the substrate bearing the fluidic pattern, is used to 
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enclose the fluidic pattern by thermally bonding it to the substrate to create the fluidic 




Figure 1.9 X-ray LiGA processing steps for making a metal mold master and molding 
on polymer substrates. The process begins with a lithography step using X-ray mask 
and a photoresist to create the desired pattern. After development, the voids left by the 
resist are filled with metal in the electroplating step to create the desired structures on a 
metal mold which is then used for molding by transferring the structures on the mold to 
the polymer substrate. Scanning electron micrograph of metal mold and polymer parts 
produced with this process are also shown. Adopted with permission.121,133  
 
the appropriate size and placed on the polymer substrate containing the fluidic patterns 
to enclose the patterns; (2) the assembly is sandwiched between glass plates and 
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clamped together; (3) heat is applied, usually in a temperature controlled oven to raise 
the temperature to slightly above the Tg of the polymer substrate for a reasonable length 
of time; (4) the assembly is allowed to cool to room temperature to generate the fluidic 
chip. 
1.4.3 Single Channel SMD 
Most flow-based single-molecule experiments are performed in a single fluidic 
channel using confocal optics (see section 1.3.1) and single element detectors such as 
a SPAD (see section 1.3.4.1). In this format, the fluidic channels provide for a conducive 
environment for effective sample manipulation and delivery while the single element 
detector and confocal configuration provide for a high sampling rate (defined by the 
response time of the detector) and high sensitivity. The sampling rate simply represents 
the frequency of data collection by the detector. For example, if a target analyte (or 
molecule) traversed the probe volume with a transit time of 1 s, a detector element with 
a respose time of 0.1 s will generate 10 data points (i.e. 10 data points per second) for 
the analyte signal to represent a Gaussian peak.134-139 While this format generates high 
detection efficiency, which is simply the percentage of molecules detected above a 
threshold value, and favorable SNR, it is characterized with a low sample processing 
throughput.140 The throughput limitation associated with single channel SMD is 
addressed using a multichannel configuration and a suitable detection system for 
parallel readout of results. 
1.4.4 Multi-Channel SMD 
In multi-channel single-molecule experiments, the samples are dynamically 
transported through a series of fluidic channels and single molecules are interrogated 
using wide-field illumination (see section 1.3.3). The resulting fluorescence signals from 
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flowing molecules in the fluidic channels are imaged onto an array detector, such as a 
CCD for parallel readout. In this configuration, the increase in throughput is directly 
related to the number of channels patterned onto the fluidic substrate that are 
interrogated. The potential of this experimental format for drastic reductions in sample 
processing times suitable for high throughput biochemical analysis has been 
demonstrated in recent reports.77,141  
There are basically two methods for excitation to perform high throughput single-
molecule experiments in a multi-channel fashion: epi-illumination and waveguide 
excitation (see section 1.3.3.1). In epi-illumination for multi-channel SMD,77 the fluidic 
channels must be configured in a high packing density format and confined within the 
excitation volume, which is defined by the optical design, such that molecules traversing 
each fluidic channel can be identified via optical imaging. The fluidic channels should 
also be constructed with the appropriate dimensions to minimize background 
fluorescence from the sample matrix. 
Waveguide excitation possesses the potential for improved sensitivity since it 
utilizes a confined evanescent field with a small penetration depth (~350 nm) and thus 
generates ultra-small probe volumes suitable for maximizing the single-molecule 
fluorescent signal. However, the challenge in this technology lies on the ability to 
fabricate an integrated system with a fluidic network and waveguide suitable for multi-
channel flow-based SMD. This configuration was recently reported by Soper’s group,142 
which employed two different substrates to create a fluidic system with integrated 
orthogonal waveguide for high throughput fluorescence measurements. Exploitation of 
this technology could expand the use of single-molecule fluorescence especially in high 
throughput biochemical screening applications. 
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1.4.5 CCD Operational Formats for Multi-Channel SMD 
CCD detection technology allows for different software-controlled operational 
modes suitable for single molecule studies in biochemical assays. The traditional 
operational mode of CCDs is the snap-shot mode, where a CCD image is taken and 
processed before the next image is captured.  This is generally characterized by a low 
duty cycle, which in this case depends on the total integration time for an image. The 
ability to track single molecules with 100% duty cycle in multi-channel SMD applications 
has been demonstrated by operating the CCD in a time-delayed integration (TDI) 
mode141 or in frame transfer mode (FTM). 77  
1.4.6 Time-Delayed Integration (TDI) Mode 
In this mode of operation, the CCD pixels of the array are exposed for the entire 
duration of an experiment to continuously collect fluorescence signals from flowing 
single molecules. The CCD chip is configured using the interface software to read out 
one row at a time instead of the entire chip. The parallel shift of the CCD is then 
synchronized with the linear velocity of the flowing single molecule so that 
photogenerated signal is collected into the same potential well of the CCD array thereby 
enhancing the SNR while at the same time increasing the duty cycle of the detection 
system.  In this case, the SNR scales with N1/2, where N is the number of rows in the 
CCD camera. A more detailed description of the TDI mode can be found in Emory et 
al.141  
1.4.7 Frame Transfer Mode (FTM) 
The FTM allows for continuous imaging with 100% duty cycle to track 
fluorescently labeled molecules at near video frame rates as the molecules traverse an 
interrogation zone. Frame transfer CCDs are constructed with the CCD chip divided into 
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two halves: a photosensitive area and a non-photosensitive (image storage) area. Once 
an image is taken, it is immediately transferred from the sensor area to the frame 
transfer area and immediately followed by another image being collected while at the 
same time, the stored image is being read out through the serial register. This allows for 
high speed imaging and it is suitable for monitoring molecular motion in fluidic systems. 
A schematic representation of a frame transfer CCD chip is shown in Figure 1.10. 
Another added feature to most frame transfer CCDs, especially the EMCCDs, is on-chip 
multiplication gain, which provide for single-molecule sensitivity. The on-chip gain is a 
signal boosting process that multiplies photo-generated charges above the read noise 
and occurs before the charges reach the readout amplifier. This process can generate 
gain factors greater than 1000x. The technology employs an extended serial register 
called a multiplication register (see Figure 1.10), where electrons are multiplied via 
impact ionization that is initiated and sustained by applying higher than typical CCD 
clock voltages (up to 50 V). For most cascade CCDs, the clock voltage is controlled by 
a 12-bit analog-to-digital (ADC) converter. This technology provides for single-molecule 
sensitivity even at supravideo frame rates.  
1.5 Biochemical Applications of SMD 
A new environment for biochemical research has been realized by emerging 
SMD techniques. In its present status, SMD has provided unprecedented insight toward 
the understanding of functional details in many biological areas such as molecular 
motors,21,143-145 nucleic acid enzymes,146-148 RNA activities,149-152 protein folding,153-156 
enzymology,157-162 gene expression,26,163 and mutational analysis.164 Detailed 
discussions on these and other applications can be found in selected reviews.22,65,165-175   
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Figure 1.10 A schematic representation of a frame transfer CCD chip with on-chip 
multiplication gain. Images are taken with the sensor area and immediately transferred 
to the frame transfer area. Prior to being read out, the collected charges that form the 
image are multiplied many times in the multiplication register to enhance sensitivity. 
 
However, specific examples are given below, which are related to two commonly 
applied assay format for HTS: receptor binding assays and competition- / inhibition-
based assays. 
1.5.1 Protein Kinase Assay 
SMD technology can be readily applied to kinase-type assays to generate high 
quality data such as molecular distribution of phosphorylated products. A typical 
example representing an indirect competition-based assay format is given in Figure 
1.11, which shows components in a kinase inhibition assay. In this illustration, the 
production of phosphorylated product is measured using the change in polarization as a 
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result of the displacement of a fluoro-labeled pre-phosphorylated peptide from the 
specific antibody.176 This has been demonstrated at Pfizer Sandwich using the first 
generation EVOscreen Mark-II technology173 to measure molecular brightness in each 
polarization direction in a kinase screening assay. In this screening platform, high 
quality measurements of fluorescence polarization were demonstrated using single 
molecule detection in a 1 µL volume of the assay.176 
 
Figure 1.11 Components in a kinase inhibition assay using antibody recognition. 
The phosphorylated product displaces a pre-phosphorylated fluoro-labeled reporter 
peptide from the antibody. 1: non-phosphorylated petide substrate, 2: 
phosphorylated peptide product, 3: pre-phosphorylated fluoro-labeled reporter 
peptide. Molecular brightness in each polarization direction arising from the free and 
antibody-bound state can be measured. Adapted with permission.176 
 
1.5.2 Membrane Receptor-Ligand Assay 
The binding of a fluoro-ligand to a sub-cellular component such as a receptor in a 
membrane preparation will generate two distinct fluorescent species due to the high 
local concentration of the membrane receptor. The two fluorescent species represent 
the free ligand and the ligand bound to the receptor (see Figure 1.12). Introduction of 
test compounds into the assay will lead to competitive binding of the test compound and 
the labeled ligand with the receptor. SMD detection technology can then be used to 
construct fluorescence intensity distributions of the different species in the assay to 
determine both the degree of binding and the populations of free and membrane-bound 
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ligand. This has been implemented using the second generation Evotec screening 
system (EVOscreen Mark-III) in a vesicle-based assay.177 The assay was configured by 
preparing vesicles from cells containing the β2 adrenergic receptor and employing a 
Rhodamine Green-labeled ligand (CGP12177A).178 Binding interactions of ligands to 
vesicles were monitored, which allowed quantification of bound and unbound ligands 
using fluorescent intensity distribution analysis (FIDA).179,180 
 
 
Figure 1.12 Schematic representation of a receptor binding assay showing the 
principle assay components. 1: free ligand, 2: autofluorescent compound, 3: 
membrane associated receptor/ligand complex. Adapted with permission.176 
 
1.5.3 Future Perspective 
SMD technologies have evolved to provide previously unattainable wealth of 
molecular information in biochemical assays. Besides the ability to distinguish different 
fluorescing species, such as bound and unbound labeled molecule in one sample, the 
techniques also provide for the ability to measure multiple, species-resolved 
parameters. For example, molecular counts, size and brightness can be measured 
simultaneously, which are useful parameters that can be used to clearly distinguish real 
hits from false positives in drug screening. In addition, artifacts induced by auto-
fluorescent compounds, biological reagents as well as technical errors can be clearly 
discriminated when analyzing SMD data, which will facilitate the drug validation process 
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by ensuring that drug candidates for clinical trial have reasonable potency for the target. 
The technology is currently driving drug discovery research to higher throughputs 
especially the high sensitivity advantage, which is a major challenge in miniaturized 
HTS. A combination of SMD with microfluidics will govern and lead the future of drug 
discovery.            
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HIGH THROUGHPUT SINGLE MOLECULE DETECTION FOR MONITORING 
BIOCHEMICAL REACTIONS* 
 
2.1 Introduction  
The ability to process large amounts of information for high throughput 
applications has become a primary ambition due in part to the large number of samples 
that must be interrogated and the complexity of those samples. An example where high 
throughput data processing is significant is in the drug discovery pipeline (i.e., high 
throughput screening) where combinatorial libraries consisting of millions of potential 
small molecule drug candidates are screened for their interaction with therapeutic 
targets using fluorescence spectroscopy as the readout modality.1-6  
  An approach toward increasing the data production rate for processing 
biochemical reactions is to increase the number of reactions run in parallel, which 
allows for analyzing a large number of targets simultaneously. This parallel processing 
is commonly carried out in titer plates, with increases in the well density used to 
increase data throughput. For example, titer plates can be configured to run 96 to 9,600 
reactions in parallel on a 3” x 5” plate.7, 8  With increases in well density also comes 
reductions in well volume, placing severe demands on the readout hardware to provide 
parallel detection to further increase throughput while at the same time providing high 
detection sensitivity and favorable limits of detection in spite of the reduced well volume.  
Other applications that require the ability to transduce large numbers of targets quickly 
include capillary array electrophoresis,9  DNA microarrays,10 small-molecule arrays,11, 12 
and protein microarrays.13 In addition, micro-Total Analysis Systems (µ-TAS) have been 
employed as a tool for increasing throughput in many applications due to their exquisite 
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characteristics conducive to high sampling rates brought about by reductions in analysis 
times and the parallelization of processing units. 14-17  
Another analytical technology, which facilitates the realization of high throughput 
biochemical data processing, is single molecule detection (SMD). SMD provides the 
ability to eliminate many sample processing steps associated with multi-step assays, 
significantly reducing assay time. This has recently been demonstrated by Wabuyele et 
al., where the overhead processing time associated with PCR amplification of target 
DNAs was eliminated by detecting single nucleotide polymorphisms (SNPs) in genomic 
DNA using single-pair FRET (spFRET).18  Using spFRET, the authors were able to 
detect SNPs in a processing time less than 5 min.  Another advantage of SMD is the 
detailed information revealed when monitoring biochemical reactions.  For example, it 
can yield insight into complex fluctuation phenomena and hidden heterogeneity that 
cannot be observed in ensemble techniques.19  
However, the challenge associated with many SMD assays is their intrinsic low 
throughput, especially for flow-based SMD experiments where a laser focused to a 
diffraction limited spot is used to interrogate material as it traverses through the 
excitation volume.20, 21  To realize the full processing potential of SMD for high 
throughput applications, the readout hardware needs to be configured in a parallel 
format without sacrificing sensitivity.   
The common approach for realizing high single molecule sensitivity is, as stated 
above, the utilization of ultra-small probe volumes, which reduces background 
interferences resulting from the sample matrix emanating from autofluorescence or 
scattering.22, 23 A common method for achieving ultra-small probe volumes is the use of 
confocal optics,24-27 in which the laser beam is focused to a diffraction-limited area 
  65
producing sampling volumes in the sub-picoliter regime. However, these confocal 
sampling volumes are usually designed with single element detectors and thus, 
generate small sample processing throughput rates.   
This limitation can be addressed by operating the readout system in a multi-
channel configuration, such that single molecules are transported through a series of 
fluidic processors that are interrogated using wide-field illumination with the resulting 
fluorescence imaged onto an array detector for parallel readout.  An array detector that 
can be employed for fluorescence imaging appropriate for single molecule high 
throughput processing is the charge coupled device (CCD).28  Advancements in CCD 
technology has made available ultra-sensitive cameras appropriate for realizing 
detection of single fluorescence molecules in flow-based measurements where the 
signal is transitory in nature.29-32  For example, Soper and coworkers33 recently 
described a CCD-based single molecule analysis system in which a flowing sample 
composed of double stranded DNA molecules labeled with an intercalating dye (TOTO-
3) were imaged onto a 1340 x 100 pixel CCD camera operated in a time-delayed 
integration (TDI) mode.33  The TDI mode was used to collect photo-generated signal 
from single multiply-labeled DNA molecules into a potential well of the CCD array as the 
molecules traversed the field-of-view (FoV), thereby enhancing the SNR at the same 
time increasing the duty cycle of the detection system.  Van Orden et al. also 
demonstrated the ability to image single DNA molecules labeled with an intercalating 
dye using a CCD operated in a snap-shot mode.34   
While the aforementioned works are excellent examples of increasing the sample 
throughput for flow-based SMD experiments, the limitations are that the single 
molecules were double-stranded DNAs loaded with multiple flours. In the case of λ-DNA 
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(~48,500 bp), each DNA molecule had a load of approximately 9,700 dye molecules. 
Therefore, high throughput flow-based SMD systems have yet to demonstrate the ability 
to detect single fluorophore molecules.    
Another viable operational modality for a CCD camera directed toward SMD is 
the frame transfer mode (FTM), which allows for high speed imaging.35, 36 For example, 
Li and Yeung utilized a frame transfer electron amplifying CCD to monitor dynamic 
conformational changes of flavin adenine dinucleotides in different media on a cover slip 
in which the molecules were immobile. Their results demonstrated the ability to monitor 
the real-time dynamics of the photoproduct formation between FAD molecules at the 
single molecule level.37 
The availability of FTM CCDs with on-chip gain has created the capability to 
study biochemical reactions at the single molecule level utilizing flow-based 
measurements in which the single molecules are dynamically transported through the 
illumination zone. These electron multiplying CCDs (EMCCDs) are equipped with a full 
frame storage region and a charge multiplication register that generates secondary 
electrons via an impact-ionization process. The net gain on these cameras can be 
greater than 1000-fold.  Although, the resulting gain has a complex relationship with the 
applied voltage, it can be estimated using the expression; 
 G = (1+g) N    (2.1) 
where G is the gain factor, g is the probability of generating secondary electrons in the 
multiplication register (typical value range from 0.01 to 0.016), and N is the number of 
pixels in the multiplication register. Thus, even with a fairly low probability of generating 
secondary electrons in the multiplication register, the cascade effect over the large 
number of stages is quite high.  For example, a CCD with N equal to 500 and g = 0.012, 
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will produce an on-chip gain of ~389. The resulting signal (St), defined by the number of 
photoelectrons generated in each pixel, can be estimated using the following 
expression;  
 St = S*QE*G    (2.2) 
where S is the number of incident photons impinging on a pixel, QE is the quantum 
efficiency at the wavelength being monitored and G is the EMCCD gain (see eq. 2.1). 
The FTM allows continuous imaging with nearly 100% duty cycle and can track 
fluorescently labeled molecules at near video frame rates as they traverse through an 
interrogation zone while the on-chip gain provides adequate sensitivity for single 
fluorophore detection.  
In this Chapter, we combined the advantages of microfluidics with a wide field 
fluorescence imaging system and present, for the first time, the ability to detect single 
chromophore molecules in a multi-channel flow-through configuration and monitor 
biochemical reactions at the single molecule/fluorophore level. The system reported 
herein provides high throughput single molecule processing capabilities using an ultra-
sensitive epi-fluorescence imaging system consisting of a FTM EMCCD with on-chip 
multiplication gain. The system possessed a large FoV (200 µm, diameter, generated by 
a 40x/0.75 microscope objective) capable of imaging a series of parallel fluidic channels 
simultaneously. As an example of the utility of this system to monitor biomolecular 
reactions at the single molecule level at relatively high processing rates, a melt analysis 
of double-stranded DNA (dsDNA) using a resonance energy transfer reporting system 
was used. The dsDNA contained a construct labeled on the 5’-end of the sense strand 
with a dye and a quencher on the 3’ end of the anti-sense strand. The number of photon 
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burst events arising from melted duplexes at different temperatures could be used to 
determine the melt profile of this double-stranded complex. 
2.2 Experimental Details 
2.2.1 Optical System  
The optical set-up for the flow-based multi-channel SMD is shown in Figure 2.1a. An 
HL6535MG laser diode (Thorlabs, Newton, NJ, USA) provided excitation (660 nm) with 
a peak power of 30 mW. The laser diode was mounted on a LDM21 (Thorlabs) laser 
mount connected to a laser driver (LDC 205, Thorlabs) and a temperature controller unit 
(TED 200, Thorlabs). The laser output was collimated using an aspheric lens (C230TM-
B, Thorlabs) and passed through a 660 nm laser line filter (660DF10, Omega Optical, 
Brattleboro, VT, USA) that was placed in the optical path of the excitation source. A 
dichroic mirror was used to direct the laser into a microscope objective (40x, 10x or 5x, 
Zeiss, Thornwood, NY, USA) and then, onto the sample after being shaped using a 
plano-convex lens (LA1509, Focal length = 100 mm, Thorlabs). The shaping lens was 
used to generate a collimated light output from the objective  with a diameter 
determined by the aperture of the objective; the diameter of the collimated light, which 
determined the FoV of the imaging system, was different for each microscope objective 
used in our experiments (0.2 mm for a 40x, NA = 0.75 objective; 0.8 mm for a 10x, NA = 
0.55 objective; and 1.6 mm for a 5x, NA = 0.12 objective).  The fluorescence emission 
from the sample was collected with the same objective from a PMMA fluidic chip and 
directed through the dichroic filter, then a band pass filter (719AF40, Omega Optical), 
and finally a long pass filter (690ALP, Omega Optical) to spectrally isolate the emission 
from scattered radiation. The isolated emission was then directed onto a reflecting 
surface of a mirror, which was placed at a 450 angle of incidence with respect to the 
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optical path to direct the fluorescence onto the CCD camera. A plano-convex lens 
(AC254-100, focal length = 100 mm) was placed between the mirror and EMCCD 




Figure 2.1 (a) Optical set-up of the imaging system using epi-illumination and 
employing a large FoV. The beam from the diode laser (λ = 660 nm) was isolated using 
a laser line filter (F1) and then shaped with a plano-convex lens (L1), which was used to 
focus the laser beam behind the input aperture of the microscope objective (OBJ). 
Following beam shaping, it was directed by a dichroic filter (DF) into the OBJ with the 
collimated laser beam impinging upon a multi-channel microchip.  The fluorescence 
signal generated from the chip was collected by this same objective, passed through the 
DF and spectrally selected using a long pass filter (F2) and an interference band pass 
filter (F3). A mirror (M) was used to steer the fluorescence signal onto a CCD after 
passing it through a lens (L2), which focused the radiation onto the photoactive area of 
the CCD. The total magnification of the system was 40x. (b) An optical micrograph 
showing a section of the multi-channel microfluidic chip; the fluidic network consisted of 
microchannels with dimensions of 30 µm wide x 20 µm deep and a pitch of 25 µm. All 
channels had a common sample input reservoir. The driving electric field was applied at 
this reservoir and another on the opposite end of the fluidic network (not shown) to drive 
the sample electrokinetically through the imaging area. (c) Diagram showing the 
operation of the CCD in a frame transfer mode with image accumulation occurring 
during single molecule travel within the FoV of the microscope. The images of single 
molecules produced streaks on the CCD due to the molecular transit time being greater 
than the CCD exposure time and multiple frames summed to produce the final image. 
Continued on next page 
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Figure 2.1 (B and C). See caption above. 
The EMCCD camera (Cascade 1K, Photometrics, Tuscon, AZ, USA) was a 
frame transfer CCD equipped with signal enhancement via on-chip gain and possessed 
8 µm x 8 µm pixels configured in a 1004 x 1002 front illumination format. The camera 
had a 10 MHz digital converter and a 16-bit digitization range. The frame transfer 
capability of the EMCCD allowed near 100% duty cycle when single molecules were 
tracked along their flow path within the illumination field. The CCD camera was 
thermoelectrically cooled to -300C to minimize dark noise and operated at the optimal 
gain to maximize the SNR in the measurement. 
2.2.2 Multi-channel Illumination 
The optical system was configured in an epi-illumination format (see Figure 2.1a) 
with beam shaping optics that generated a collimated output of the excitation source 
through the microscope objective for wide-field illumination. The collimated beam was 








laser power of ~25 mW generating an irradiance of 1.9 x 1020 photons cm-2 s-1 for the 
40x objective.  For a dye such as AlexaFluor 660 that possesses an absorption cross 
section of 1.82 x 10-16 cm2 (molar absorptivity = 110,000 cm-1M-1) and a fluorescence 
lifetime of ~1 ns, optical saturation occurs at an irradiance of ~5.4 x 1024.  Therefore, the 
system is currently being operated well below optical saturation.   
2.2.3 Microfluidic Design 
A PMMA microchip was designed for high throughput single molecule data 
processing that consisted of a series of flow channels tightly packed to provide the 
ability to image a number of single molecule experiments within the microscope’s FoV. 
The microfluidic devices were fabricated via direct milling of the fluidic vias into a PMMA 
wafer using a Kern MMP2522 micromilling machine (KERN micro-und 
Feinwerktechnick, GmbH & CO, Murnau Westried, Germany). The device consisted of a 
series of microchannels with dimensions of 30 µm in width, 20 µm in depth and a pitch 
of 25 µm.  All channels possessed a common sample reservoir (Figure 2.1b). Following 
micromilling, the device was sonicated for 1 min in IPA and rinsed thoroughly with 
deionized water. A PMMA cover plate (125 µm thickness) was placed on the device to 
enclose the microfluidic channels. The chip assembly was clamped between two glass 
plates and annealed in a GC oven at 107oC (slightly above the Tg of PMMA) for 22 min. 
2.2.4 Chemicals and Reagents 
Stock solutions of Tris-Taps-EDTA (TTE) buffer (10x) were diluted to obtain 1x 
TTE solutions (pH = 8.7) using nanopure water obtained from a Barnstead NANOpure 
System (Model D8991, Dubuque, IA). Fluorescence reagents used included AlexaFluor 
660 and Syto-63 (Molecular Probes, Eugene, Oregon, USA). λ-DNA (48.5 kbp) was 
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obtained from Molecular Probes and diluted in 1x TTE buffer to the required 
concentration after being labeled with Syto-63 at a molar ratio of 5:1 (bp:dye). Single 
stranded DNA (ssDNA, 60 bases in length) were 5’ labeled with AlexaFluor 660 
(Molecular Probes) and a stock solution (80 nM) was prepared using a 1x TTE buffer. 
Double-stranded DNA (dsDNA, 15 bp in length) was obtained from Molecular Probes as 
well; the duplex had the sense strand labeled with AlexaFluor 660 at  its 5’ end while the 
complementary strand (anti-sense strand) was labeled with BHQ-3 at is 3’ end. Stock 
solutions (0.4 μM) of the duplex were prepared in Tris/HCl buffer containing 20 mM Tris-
HCl, 10 mM MgCl2 and 10 mM KCl at pH 7.5. Dilutions from this stock solution to the 
desired concentrations required for the single molecule experiments was accomplished 
with the same buffer. In all cases, buffer solutions were filtered through 0.2 µm filters 
prior to sample preparation.   
Stock solutions of λ-DNA molecules were labeled with an intercalating dye (Syto-
63) and diluted in 1x TTE buffer to 10 pM. This concentration was selected to keep the 
single molecule occupancy probability low to reduce the double occupancy probability. 
With the system possessing a probe volume of 0.8 fL (CCD pixel size = 8 μm x 8 µm), a 
sample concentration of 100 pM produced a single molecule occupancy probability of 
0.01 (probability of double occupancy = 0.0001). 
2.2.5 Single Molecule Tracking via Frame Transfer EMCCD Operation 
The system was optimized for its single molecule sensitivity when operated in the 
frame transfer mode using λ-DNA (48.5 kpb) labeled with Syto-63 and diluted in 1x TTE 
buffer.  Single λ-DNA molecules were loaded into the common sample reservoir of the 
PMMA wafer and driven through the microfluidic channels by electrokinetic pumping 
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using a high voltage power source (Spellman CZE1000R, Hauppauge, NY, USA). The 
movement of the molecules through the illumination zone generated streak images for 
each single DNA molecule when the system was operated in the frame transfer mode 
and multiple images could be combined.  A schematic representation of this process 
(frame transfer with image accumulation) is shown in Figure 2.1c. A streak image 
resulted from the collection of fluorescence signal from the same molecule into potential 
wells along a single column of the EMCCD as the molecule migrated through the FoV.  
The single fluorophore detection capability of the system was evaluated using 
DNA molecules that were end-labeled with a single AlexaFluor 660 dye molecule.  In 
this case, only a single image frame was used for the presented data due to the short 
bleaching lifetimes associated with single chromophore assemblies. 
2.2.6 Bulk Fluorescence Measurements 
 Emission spectra of the duplexed DNA/AlexaFluor 660 constructs used for the 
bulk melt analyses were acquired using a FLUOROLOG-3 spectrofluorometer (Horiba 
Jobin Yvon, Edison, NJ). The spectrometer was equipped with a 450 W xenon lamp and 
a cooled Hamamatsu R928 extended-red photomultiplier that was operated at 900 V in 
the photon-counting mode. The cuvette was thermostatically controlled in order to 
provide the required temperatures for the melt analysis. 
2.3 Results and Discussion 
2.3.1 Multichannel Illumination and System Optimization 
The optical system was operated using epi-illumination (see Figure 2.1a) with 
beam shaping of the laser source to generate a collimated light output from the 
microscope objective for wide-field illumination to provide the simultaneous excitation of 
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fluorophores traversing through a series of channels contained within the objective’s 
FoV. The channel dimensions of the fluidic network were 30 µm (width) x 20 µm 
(depth), with the depth selected to provide sufficient single molecule sampling efficiency 
(SE), which was determined by the depth of focus of the microscope objective used for 
collecting the fluorescence (1.4 µm for 40x objective; 6.6 µm for 10x objective; and 60.1 
µm for the 5x objective), and the percentage of molecules traveling through the 
illumination zone, which in this case is near 100%. The 40x objective (NA = 0.75) was 
used for single fluorophore measurements due to its high collection efficiency in spite of 
its smaller depth of focus. Therefore, the SE for our system for single fluorophores was 
approximately 7% (100% x 1.4/20). However, we are not using a pinhole aperture in the 
secondary image plane of the relay objective, which will allow for a larger depth of focus 
for the optical system than that calculated above and as such, the SE determined above 
should be considered a minimum estimation only.   
The 40x objective generated a FoV of 200 µm, which allowed imaging 5 
microchannels with the current fluidic architecture. Changing the imaging objective to a 
lower magnification would allow for the processing of more fluidic channels (see Table 
2.1). For example, the use of a 5x objective would provide the ability to image 30 
channels with the channel architecture used herein due to its larger FoV. However, the 
cost for this higher throughput is reductions in the collection efficiency of the resulting 
fluorescence emission, which could potentially reduce single molecule sensitivity.  
Clearly, reductions in the channel width and pitch could significantly improve the 
number of channels we could image.  For example, using a microfluidic chip with a 1 µm 
wide channel and a pitch of 1 µm, which can be fabricated using optical lithography, 
would permit the ability to image 100 such channels for a FoV of 200 µm. 
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of View (FoV) 
Number of 
channels  within 
the FoV (30 µm 











40x/0.75 200 µm 5 810 6.7 x 104 
10x/0.5 800 µm 17 510 2.28 x 105 
5x/0.25 1.6 mm 30 314 4.02 x 105 
  
2.3.2 Detection of Single λ-DNA Molecules 
Experiments were first carried out at different electric field strengths to establish the 
transport velocity that would yield optimal signal-to-noise ratio (SNR) for the single 
molecules, which in this case were λ-DNA molecules stained with Syto-63, since the 
molecular transit time should be approximately equal to the photobleaching time to 
provide the highest SNR.38 Results from 10 different measurements were averaged and 
plotted versus the applied field strength, which generated an optimal field strength of 
~80 V/cm (see Figure 2.2a). At this field strength, the linear velocity was 0.01 cm/s, 
which was based on the applied field strength and the electrophoretic mobility of λ-DNA 
loaded with Syto-63. At this linear velocity and FoV, the molecular transit time was 
estimated to be ~1.6 s.  We note that the processing rate is directly related to the flow 
velocity for flow-based measurements and as such, higher field strengths would result in 
higher system throughput. Even at field strengths of 300 V/cm (0.037 cm/s), we were 
able to generate sufficient SNR to detect single λ-DNA molecules. 
  76
                a 
               
 b 
    
Figure 2.2 (a) Plot of the signal-to-noise ratio (SNR) at different field strengths used to 
transport single molecules through the irradiation zone of the imaging system. The SNR 
values were obtained from an average of 10 different measurements. (b) Fluorescence 
image from the CCD for a single molecule tracked along several pixels of the CCD, 
which was accumulated from two image frames that were acquired using 100 ms 















To demonstrate the ability to track single dsDNA molecules traveling 
electrokinetically through the irradiation zone, experiments were carried out using single 
and multiple microchannels.  Figure 2.2b shows a fluorescence image of a single DNA 
molecule tracked along the FoV of the imaging system by accumulating two image 
frames acquired using a 100 ms exposure time per frame. From the length of the streak 
(~60 µm) and the image accumulation time (2 frames at 100 ms per frame), we 
estimated the linear velocity to be 0.03 cm/s, very close to that determined above at a 
field strength of 300 V/cm. 
To evaluate the sample throughput (ST) capabilities of the system, a 100 pM solution of 
λ-DNA was electrokinetically driven through the system at a field strength of 300 V/cm 
and the fluorescence image was collected using the 10x objective (NA = 0.5); the FoV 
of the system was 800 μm, which allowed imaging 17 channels. With the system 
operated in a frame transfer mode, the SMD sensitivity was improved by using 3x 
binning (3 x 3) with the multiplication gain of the EMCCD set at 3,700. Figure 3a shows 
one image frame from a series of images acquired for single λ-DNA molecules stained 
with Syto-63 traveling through the illumination zone. Each fluorescent streak represents 
an individual DNA molecule migrating through the chip due to the low probability of 
double occupancy per imaging pixel at this DNA concentration. The intensity distribution 
of this image was constructed by transforming the image in Figure 3a to a 3-D image 
(see Figure 2.3b).  
To further demonstrate the ability to increase the throughput of the multi-channel 
fluidic device, a 5x objective (NA = 0.25) was incorporated into the imaging system and 
the same sample concentration of λ-DNA as that use above (100 pM) was analyzed.  
Figure 2.3c presents a single  image frame  showing  photon bursts  from  single λ-DNA  
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Figure 2.3 (a) Image of single λ-DNA molecules migrating through a series of 
microchannels (17-channels are shown). The image was acquired using a 10x (NA = 
0.5) objective at an exposure time of 100 ms with the CCD multiplication gain set at 
3,700 (controller gain set at 1). The sample solution (100 pM) was electrokinetically 
pumped through the fluidic channels with a field strength of 300 V/cm (linear velocity = 
0.037 cm/s). Each fluorescent spot represents a single λ-DNA molecule. (b) 3-D image 
showing the intensity distribution of λ-DNA molecules shown in (a). (c) Single λ-DNA 
molecules migrating through series of 25 microchannels. Image was acquired using a 
5x objective (NA=0.25). In all cases, the λ-DNA was stained with Syto-63 at a dye to 
base pair ratio of 5 to 1. Continued on next page 













Figure 2.3 (C) see caption above. 
 
molecules in 25 different microchannels. This objective generated a FoV of 1.6 mm, 
which allowed imaging 30 channels using our present fluidic architecture, but only 25 
are shown in Figure 3c. Therefore, the single molecule processing throughput was 
increased by a factor of 6 compared to the 40X objective due to the higher FoV afforded 
by the lower power objective.   
For flow-based single molecule detection experiments in which the single 
molecule events are dynamically transported through a fixed interrogation (sampling) 
zone, the sample throughput (ST) can be calculated from;33 
DCDRDESEST ×××=  (2.3) 
 
where SE represents the percentage of molecules that are sampled during the 
experimental run (1.0 for the 5x objective), DR is the delivery rate of molecules into the 
sampling volume, DC is the readout duty cycle (1.0) and DE is the detection efficiency.  
The DR can be calculated using; 
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bv CFDR ×=               (2.4) 
 
where Fv represents the volume flow rate (cm3 s-1) and Cb is the molecular 
concentration (molecules cm-3).  DE is basically the percentage of molecules detected 
above a threshold value, which is selected to minimize the number of false positive 
events registered during the experiment.   For the present experiments, using a field 
strength of 300 V/cm and 100 pM concentration, the DR was determined to be 1.34 x 
104 molecules s-1. For DE = 1 and SE = 1.0, a ST of λ-DNA was estimated to be 13,400 
molecules/s in each microchannel with a total system throughput of 4.02 x 105 
molecules/s in the 30 channel network.  
As noted above, scaling down the microchannel width and pitch can be used to 
further increase the ST of the present system.  For example, reducing the channel width 
to 3 μm with a pitch of 3 μm and using the 10X objective to produce a reasonable 
collection efficiency (NA = 0.5), will increase the number of channels that can be imaged 
to 133 with a corresponding ST of 1.78 x 106.  A further reduction in channel width to 1 
µm with an inter-channel spacing of ~400 nm (diffraction limited resolution is ~λ/2) will 
allow the system to image 571 microchannels using the 10x objective increasing ST to 
7.65 x 106 molecules/s.  While this represents a significant increase in ST over our 
previous work 33, it also indicates exceptional increase in ST over previous research 
reports.34, 39-46 For example, Van Orden et al. reported a ST of 2000 DNA fragments s-1 
using a CCD operated in a snap-shot mode ,34  while Ma et al. reported an ST of ~ 8500 
molecules s-1 from their single molecule spectroscopy studies.43 Recently, Chansin et 
al. speculated a throughput of ~1500 molecules s-1 using their synthetic nanopores to 
measure DNA translocation events.46 
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2.3.3 Detection of Single DNA/Fluorophore Conjugates  
For these experiments, we utilized the 40x (NA = 0.75) objective and the optimized field 
strength (80 V/cm) for producing a high single molecule SNR to enhance sensitivity for 
the detection of single fluorophore molecules that were conjugated to ssDNAs. 
Solutions of ssDNAs labeled with AlexaFluor 660 were prepared in 1x TTE buffer and 
diluted to 750 pM in the same buffer. The samples were electrokinetically pumped 
through the microfluidic network and an exposure time of 100 ms was selected for the 
CCD per image frame when operated in FTM.  With the 40x microscope objective, the 
laser excitation volume was calculated to be 0.12 nL, which in this case is not the 
sample probe volume due to the fact that the irradiation area was sub-divided into 
smaller elements defined by the pixels comprising the EMCCD camera.  The probe 
volume was actually calculated from the size of each individual pixel of the EMCCD (8 
µm x 8 µm) and the total magnification of the optical system (40x), producing a probe 
volume of 0.8 fL.  Based on this probe volume size and the concentration used for these 
experiments (750 pM), the single molecule occupancy was 0.3 and the double 
occupancy probability was 0.09.  Figure 2.4a shows a fluorescence image of individual 
ssDNA molecules end-labeled with AlexaFluor 660 migrating through the fluidic device.  
From this image, single molecule streaks were not observed as was seen in Figure 
2.2b. This was a result of the binning operation performed on the image (3 x 3 bin), the 
relatively small linear velocity used and the data image shown in Figure 2.4a taken from 
a single frame. To enhance spot visualization of the single molecules, we acquired 10 
images of the blank (1x TTE buffer) from which the standard deviation was calculated, 
which was found to be 42 units for an average background of 2,019 CCD units per pixel; 
a threshold value was selected as 3-times the standard deviation above the average 
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background (2,145), which was subtracted from a sample sub-frame (25 x 42 pixels) as 
indicated in Figure 2.4a. This also reduced false positive signals resulting from 
statistical variations in the background.  Application of this threshold condition 
generated the sub-frame image shown in Figure 2.4a. This sub-frame represents 
approximately a 5 µm (wide) x 8.4 µm (length) area within a single microchannel. From 
this image, fluorescence from single molecules were clearly visible, which could be 
individually counted to extract quantitative information.  This same operation was 
applied to an image acquired when there was only buffer in the microfluidic network with 
this image shown in Figure 2.4b.  As can be seen from this image, there was no 
fluorescence registered as that observed in Figure 2.4a.  
a 
 
Figure 2.4 (a) Detection of individual dye molecules (AlexaFluor 660) end-labeled to a 
60 base ssDNA distributed in different microfluidic channels (5 channels are shown) for 
a sample concentration of 750 pM. The dye/ssDNA conjugate was pumped through the 
fluidic channels using a field strength of 80 V/cm (linear velocity = 0.01 cm/s). To further 
visualize the fluorescent photon bursts in this image, a sub-frame (25 x 42 pixels) was 
expanded and quantitative information extracted by applying a threshold condition to 
this sub-frame (see text for details). (b) Image acquired when the fluidic channels were 
filled with buffer only, and the processed sub-frame with application of the threshold 








Figure 2.4(b) see caption above. 
 
 From careful inspection of the sub-frame image shown in Figure 2.4a, we were 
able to count 64 photon bursts generated from single ssDNA-AlexaFluor 660 
conjugates.  From the size of the image taken (5 x 8.4 x 1.4 µm3, Pv) and the 
concentration of the conjugates used herein (750 pM, Cb), we could calculate the 
number of expected events (Nev) from; 
Nev = Cb Pv    (2.5) 
Insertion of the appropriate numbers into eq. 2.5 yielded a value of 26, which is 
somewhat smaller than the 64 events observed in the image sub-frame shown in Figure 
2.4a. This can be reconciled considering that the probing volume was determined by the 
depth of focus of the microscope objective used here.  Because there is no pinhole 
(confocal geometry) located in the secondary image plane of the objective, we are 
processing molecules outside of the 1.4 µm depth of focus of this 40x objective, making 




irection of Transport 
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Different concentrations of ssDNA-AlexaFlour 660 conjugates were next 
evaluated using our multi-channel single molecule detector system and processed with 
the same threshold value as noted above.  An average of eight images per dye 
concentration was plotted with the calibration plot constructed from the number of 
photon burst events versus the conjugate concentration. This analysis was performed 
on a sub-frame image with a size of 25 x 42 CCD pixels. The number of spots (single 
molecule events) observed was linear with the sample concentration yielding a 
correlation factor of 0.98 (data not shown). 
2.3.4 Fluorescence Quenching Assay 
            We were next interested in evaluating the capability of our imaging system to 
monitor biochemical reactions using fluorescent probes to signal the extent of the 
reaction. We employed a model test case using an oligonucleotide duplex (15 bp) with 
one strand (sense strand) labeled with AlexaFluor 660 at its 5’ end and the 
complementary strand (anti-sense strand) labeled with the Black Hole Quencher-3 
(BHQ-3) at its 3’ end to create sufficient proximity for resonance energy transfer 
quenching of the fluorescence from AlexaFluor 660 for the duplexed form of this 
construct (see Figure 2.5a). Melting of the duplex could be affected by introducing 
thermal energy into the system, producing ssDNAs that would result in the generation of 
fluorescence from the sense strand. Therefore, a melt analysis for this oligonucleotide 
could be generated by plotting the number of single molecule events observed from the 
sense strand versus the temperature. 
For these experiments, the duplexed samples (750 pM) were prepared in 
Tris/HCl buffer containing 20 mM Tris-HCl, 10 mM MgCl2 and 10 mM KCl at pH 7.5.  
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The microfluidic device was equipped with a strip heater, which was placed 200 µm 
upstream from the imaging area. The duplexes were electrokinetically driven through 
the fluidic device at the desired temperature using an 80 V/cm field strength. When 
operated at room temperature, there was no fluorescence signal registered on the 
detector. The absence of fluorescence photon bursts in the EMCCD image clearly 
indicated that the reporter dye was sufficiently quenched by BHQ-3 and no single 
stranded constructs could be seen (data not shown). This is in agreement with previous 














Figure 2.5 (a) Fluorescence single molecule quenching assay for determining duplex 
Tm using a 15-base pair oligonucleotide labeled with AlexaFluor 660 on its 5’ end and its 
complement labeled with the Black Hole Quencher-3 (BHQ-3) on its 3’ end. (b) 
Fluorescence single molecule image of the 15-bp oligonucleotide when the sample was 
heated to 67oC. Fluorescence from single DNA/AlexaFluor 660 molecules were visible 
as shown in this image due to duplex melting, producing ssDNAs.  Also shown is the 
sub-frame of this image (37 x 67 pixels) that was processed as described in Figure 4. 
(c) Plot of number of single molecule events counted over a fixed interval of time at 
different sample temperatures (rectangles, concentration = 750 pM). Also shown is a 
plot of the normalized fluorescence intensity of the duplexed DNA at different 
temperatures using a bulk measurement (dsDNA concentration = 40 nM, circles; and 1 







Figure 2.5 (b and c) See caption above. 
To generate ssDNA in the flowing sample, the strip heater was then turned on 
with the temperature set to 67oC. Figure 2.5b shows a single molecule fluorescence 
image of photon bursts generated from the ssDNA constructs when imaged at this 
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temperature.  To clearly visualize these spots and extract quantitative information by 
counting the single molecule events, the threshold condition was applied as discussed 
earlier. A sub-frame (37 x 67 pixels) was selected and processed (see Figure 2.5b). The 
presence of fluorescent photon bursts in the 67oC image versus that taken at room 
temperature is expected; the thermal energy introduced into the system produced a 
sufficient population of ssDNAs due to thermal denaturation of the duplexed DNA and 
thus, the energy transfer interaction between the two labels is eliminated because of 
proximity considerations.  
A melt analysis was then conducted on the oligonucleotide duplex by taking 
images of single molecules traversing through the interrogation zone at different 
temperatures and counting the number of events (i.e., ssDNAs) at each temperature 
investigated. This analysis generated a sigmoidally-shaped plot (see Figure 2.5c) with a 
sharp rise in the number of single molecule events between 30oC and 50oC with a 
midpoint at ~40oC. This midpoint represents the melting temperature (Tm) of the duplex, 
which is defined as the temperature in which 50% of the DNA is in its double-stranded 
form and 50% in its single-stranded form. This value agrees favorably with that obtained 
from a theoretical prediction (Tm = 41.7oC) using oligonucleotide analysis software.48, 49 
The melting temperature of the duplex was also estimated by measuring fluorescence 
from a bulk sample of the duplex (1 nM) as a function of temperature using a standard 
fluorometer (λex = 675 nm). Figure 2.5c shows the resulting plot of fluorescence intensity 
obtained at various temperatures, which generated a Tm value of 43oC.  The slight 
deviation of this value (43oC) compared to the single molecule result could be attributed 
to the slightly higher concentration of the duplex used in the bulk solution since the 
inter-strand duplex Tm depends on concentration.48  This supposition was further 
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supported by the experimental Tm (50oC) obtained for a 40 nM solution of this same 
duplex (see Figure 2.5c). 
As an example of the necessity for high throughput processing required to 
perform this measurement, we were able to reduced the processing time by a factor 
directly related to the number of channels imaged during the single molecule 
measurement, which in this case yielded a 5-fold reduction in processing time 
compared to a single point SMD flow-based scenario. Implementation of a smaller 
microchannel width and pitch producing a higher packing density of channels would 
significantly increase the data processing rate. For 1 µm wide channels and a pitch of 
400 nm, the number of channels that could be effectively imaged using a 200 µm FoV 
would be 143 channels, reducing the processing time by 143-fold.  
2.4  Conclusion 
We have demonstrated the ability to detect single molecules using a frame 
transfer EMCCD in a high throughput format using a series of microchannels packed 
into the FoV of our imaging system. The system was configured in an epi-illumination 
format with beam shaping optics to generate a collimated output adequate for wide field 
illumination and providing adequate irradiance and SNR to observe photon bursts from 
single fluorophore molecules. The present design allowed imaging 30 microchannels 
when λ-DNAs were stained with an intercalating dye. This represents a 12-fold increase 
in the sample throughput (4.02 x 105 molecules/s) over our previous work, which 
employed a CCD operated in a time-delayed integration mode.33  The reported optical 
system also provided, for the first time, single fluorophore sensitivity for a multi-channel 
flow-based single molecule experiment as demonstrated by the photon burst detection 
of ssDNAs end-labeled with AlexaFluor 660. However, in this case, a 40X objective with 
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its high NA was required to collect sufficient numbers of fluorescent photons to produce 
adequate SNR for detection of these single fluorophore molecules. This resulted in a 
decrease in the system sample processing throughput due to the reduced FoV (200 µm 
vs. 1,600 µm for a 5X objective), which permitted the simultaneous interrogation of 5 
channels (40x objective) versus 30 channels (5x objective). However, reducing the 
microchannel width and pitch can significantly improve the sampling throughput for the 
40x objective using optical lithography to produce a molding tool for micro-replicating 
high density fluidic networks in polymers, such as PMMA. 
The results obtained from a fluorescence quenching assay associated with DNA 
duplex melting demonstrated the ability of our system to generate high throughput data 
processing appropriate for evaluating the fate of a biochemical reaction by monitoring 
population differences between reactants and/or products in a single molecule 
approach. The appealing aspect of the single molecule approach is the ability to use low 
concentrations of precious biological reactants and enzymes, the exquisite sensitivity 
associated with single molecule detection to record subtle changes in the reaction 
profile and the ability to monitor reactions efficiently in ultra-small volumes.  This will be 
particularly attractive for high throughput screening applications, where the effects of 
elements from a large combinatorial library must be screened against a therapeutic 
target (i.e., bioenzyme). Due to the large size of most combinatorial libraries (>106 
elements), high throughput processing is critical.  
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CYCLIC OLEFIN COPOLYMER PLANAR WAVEGUIDE EMBEDDED IN A MULTI-
CHANNEL POLY (METHYL METHACRYLATE) FLUIDIC CHIP FOR EVANESCENCE 
EXCITATION 
 
3.1  Introduction  
Lab-on-a-chip (LOC) systems offer a number of compelling advantages compared to 
conventional bench-top systems, including the ability to process large amounts of 
chemical/biochemical information due to the ability to build chips in a highly parallel 
fashion.1-6 A major challenge associated with these miniaturized systems is the 
associated reduced sample and reagent volume requirements, which place a high 
demand on the detection system to provide the required sensitivity for interrogating a 
few molecules present in the resulting detection volume. Whilst several detection 
methods exist for microfluidic systems,7,8 laser-induced fluorescence (LIF) has been 
widely adopted due to the high sensitivity, selectivity and extremely low limits-of-
detection obtainable.9,10  
Classical optical configurations for LIF are often based on epi-illumination or trans-
illumination formats,11,12 in which both excitation and fluorescence light propagate in the 
same optical path with spectral sorting accomplished using dichroic filters. Another 
optical configuration, which has found applications in LIF detection, is total internal 
reflection (TIR) fluorescence,13-15 in which fluorescent samples are excited using a 
surface-confined excitation field. Several reports have documented the use of TIR 
optics which use prisms,16-18 microscope objectives,19,20 and optical fibers.21,22 In all 
cases, fluorescence excitation utilized the evanescent field generated by TIR at a high 
refractive index to a low refractive index boundary.  
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The penetration depth of the evanescent field is usually fairly small (<750 nm) with 
the absolute value dependent upon the excitation wavelength, the refractive indices of 
the waveguiding material and substrate and the launch angle of the incident light. The 
intensity of the evanescent field, which is proportional to the square of the electric field 
amplitude,23 normally drops off exponentially into the lower index medium, thus enabling 
the realization of small excitation volumes. 
A common class of materials used for TIR fluorescence is optical 
waveguides,24,25 which offer a number of advantages, such as the realization of 
compact sensing elements suitable for LOC applications and the potential for fabricating 
multiple sensors on a single chip.26 Planar waveguides for biosensing applications have 
been made using a variety of materials such as metal films,27 metal oxide films,28  
photonic crystals,29,30 and silicon oxynitride.31 While glass remains the most commonly 
used material for waveguide applications,15,32 its incorporation into other sample 
processing units required for LOC sensing is a challenge due to its limited and 
sometimes costly fabrication modalities. As a result, polymer-based waveguides33,34 
have attracted much interest in many LOC applications because of their simple 
fabrication characteristics and in some cases, their favorable optical properties.35 Also, 
the ease of integrating these materials into instruments suitable for point of care (POC) 
applications is of great value. 
 Several polymer materials have been employed for waveguiding, including 
poly(dimethylsiloxane), PDMS,36,37 SU-8,26,38-40 and poly(methyl methacrylate), PMMA.41 
As an example, Xu et al.41 recently demonstrated the use of a PMMA-based air-
embedded planar waveguide for reading DNA microarrays. This waveguide was 
fabricated in a single step using double-sided hot embossing from metal mold masters.  
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Another polymeric material, which holds great promise as a waveguide material, is 
cyclic olefin copolymer (COC). This class of polymers has properties that can be 
tailored within a wide range of characteristics during polymerization.42 COC is a 
copolymer of ethylene and norbornene produced via a metallocene catalyst-mediated 
polymerization with glass transition temperatures (Tg) that range from 75oC to 180oC 
and depends on the amount of norbornene in the copolymer. COC possesses high 
optical transparency, excellent electric properties, high rigidity, excellent 
biocompatibility, very good resistance to acids and alkalis and good thermal 
properties.42,43 Several works have reported on the microfabrication of COC 
substrates,44-49 which have created avenues for expanding the utility of this polymer 
especially as a waveguide material due to its exquisite optical properties.50  
Although much progress has been made toward integrating waveguides to 
microfluidic systems,14,51-53 effective propagation of light through a single planar 
waveguide for evanescent excitation in multiple fluidic channels suitable for high 
throughput biochemical analysis has not been reported. In this Chapter, we present for 
the first time the fabrication of a COC waveguide that was embedded in a PMMA 
substrate serving as a cover plate for a PMMA substrate that contained a series of 
fluidic vias. The COC waveguide was situated orthogonal to the microfluidic channels to 
provide parallel evanescent excitation of the material moving through the fluidic vias. 
The fluidic channels were hot embossed from a metal master on a 250 µm thick PMMA 
sheet, which was thermally fusion bonded to the PMMA cover plate containing the 
embedded COC waveguide. To carefully control the laser launch angle into the 
waveguide to near the critical angle, which is defined by the refractive index of COC (n 
= 1.53) and PMMA (n = 1.48), a monolithic prism was integrated to the COC waveguide 
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in a single fabrication step, eliminating the need for an external prism and index 
matching oil. In another design, laser light was coupled to the embedded waveguide 
through an optical fiber (N.A. = 0.12), which minimized light loss due to scattering.  
3.2  Experimental   
3.2.1 Materials and Reagents  
COC sheets (grade: 5010L; Tg = 110oC; n = 1.53) were obtained from Topas 
(Topas Advanced Polymer, USA); the molecular structure of Topas COC is shown in 
Figure 3.1a with the monomer units represented as x and y. Toluene was obtained from 
Fisher Scientific (Fisher Chemicals, USA) and used as supplied to make a polymer 
solution of COC.  The COC solution was obtained by dissolving pieces of COC in 
toluene, which made a clear solution of the polymer in 24 h.  A PDMS base and curing 
agents were obtained from Dow Corning (Dow Corning Corporation, Midland, USA.). 
Optical fibers (NA = 0.12) were obtained from Thorlabs (Thorlabs,  Newton, NJ, USA) 
with the blunt bare fiber end created using a fiber optic cutting tool (Precision Tool kit, 
698-STK-100). AlexaFluor 647 was obtained from Molecular Probes (Eugene, Oregon, 
USA) with the stock and sample solutions made in 1X  Tris-Taps-EDTA (TTE) buffer 
(pH = 8.7).  
3.2.2 Image Acquisition 
All fluorescence images were acquired using a Roper Scientific (Trenton, NJ) 
Spec-10 charge-coupled device (CCD) camera that was thermally cooled to -90oC and 
contain a 1 MHz digital converter. The CCD had 20 µm pixel sizes that were configured 
in a 1340 x 100 back-illuminated format. Scanning electron micrograph (SEMs) images 
were acquired using a Cambridge S-260 SEM (Cambridge instruments Ltd. Cambridge, 
UK) interfaced with Video Wave 5 program (Real Networks Inc. Washington, USA). 
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Atomic force microscopy (AFM) images were acquired using a Nanoscope III instrument 





Figure 3.1 (a) Molecular structure of Topas COC, x and y represent the monomer units, 
which are polymerized by metallocene catalyzed polymerization; the Tg can be modified 
by increasing or decreasing the amount of norbornene (y) in the monomer mixture 
during polymerization. (b) Schematic representation of the fluidic device with embedded 
COC core waveguide fabricated with a monolithic prism. (c) Schematic of a dissected 
portion of the device showing the multi-channel fluidic architecture and waveguide 
geometry. (d) Diagram showing the launching of laser light into the waveguide using an 
optical fiber. 
 
3.2.3 Layout of the Integrated System 
Figure 3.1b shows a schematic diagram of the multi-channel fluidic device with 
an embedded COC core waveguide and monolithic prism. The device consisted of two 
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layers; a PMMA cover plate (refractive index, n, = 1.48, Tg = 107oC) into which the COC 
core waveguide (refractive index, n = 1.53) was embedded and a PMMA substrate, 
which contained the fluidic channels that were replicated/embossed from a metal mold 
master (see Figure 3.1c).  The waveguide was situated orthogonal to the longitudinal 
axis of the fluidic channels along the width of the PMMA cover plate, the size of which 
defined the excitation volume in each fluidic channel along with the penetration depth of 
the evanescent field. The monolithic prism (see Figure 3.1b) facilitated coupling of light 
into the waveguide without the need for an external prism or index matching oil. Figure 
3.1d is a schematic of the optical fiber coupled COC core waveguide. The use of the 
optical fiber in this design eliminated the need for a prism. 
3.2.4 Fabrication of the Embedded Waveguide 
The stepwise fabrication process for creating the embedded COC core 
orthogonal planar waveguide and monolithic prism is shown in Figure 3.2a. The first 
step involved the generation of a PDMS stencil, which was used to form the waveguide 
and coupling prism and was produced using a relief made from PMMA. The PMMA 
relief consisted of a prism-shaped structure that was aligned to a 1 mm diameter pole 
structure (height of structure = 2.0 mm) used to create an access reservoir. The PMMA 
relief was replicated from a brass mold master fabricated by high precision micromilling 
(using Kern MMP micromilling and drilling machine).54,55  A PDMS pre-polymer solution 
was obtained by mixing the PDMS base and the curing agent at a ratio of 10:1 by mass. 
This solution was degassed and loaded through the injection port of a molding frame 
containing the PMMA relief to completely fill the mold cavity. Curing of the PDMS pre-
polymer solution was achieved in 1.5 h using a vacuum oven set at 70oC. The resulting 
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PDMS stencil containing the prism-shaped recess and a 1 mm diameter reservoir 
(created by the 1 mm diameter pole) was peeled from the PMMA relief.  
The PDMS stencil was then placed onto a sheet of PMMA containing a pre-
fabricated waveguide channel (200 µm x 200 µm). The waveguide channel was 
replicated onto the sheet PMMA from a brass mold master that was fabricated by high 
precision micromilling. The prism-shaped recess on the PDMS stencil and the reservoir 
were carefully aligned with both ends of the waveguide channel under a microscope. A 
COC solution (melt) was then introduced into the waveguide channel through the 
reservoir to fill the channel and the prism-shaped recess. This assembly was placed on 
a dry glass plate and allowed to cure in a vacuum oven for 24 h at room temperature. 
Following curing of the COC, the PDMS stencil was carefully peeled from the PMMA 
sheet, which formed the embedded COC core waveguide and the monolithic coupling 
prism. Figure 3.2b shows an image of the embedded COC waveguide with monolithic 
prism. 
3.2.5 Fabrication of the Optical-Fiber-Coupled (OFC) Waveguide 
The OFC waveguide was fabricated following the procedure outlined in Figure 
3.2a with slight modifications. In this case, the prism-shaped structure in the mold (see 
Figure 3.2a (i)) was replaced with a second pole (1 mm diameter and 2 mm tall), which 
allowed the generation of a PDMS stencil with two aligned reservoirs (each situated at 
both ends of the PDMS stencil). An optical fiber (OD = 125 µm, core diameter = 62 µm) 
was cleaned with acetone and inserted into the waveguide channel with the tip of the 
fiber situated 5 mm from the insertion end of the channel. The optical fiber was kept in 
place using the fabricated PDMS stencil, which was placed on the PMMA wafer with the 
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reservoirs aligned to the ends of the waveguide channel and subsequently clamped to a 
glass plate. The COC melt was introduced into the waveguide channel through the  
(a) 
 
Figure 3.2 (a) Schematic representation of the stepwise process for the fabrication of 
the embedded COC core orthogonal waveguide. In the first step, the mold structures 
were fabricated in PMMA wafer via hot embossing from a mold master made using high 
precision micromilling (i).  The mold was assembled for PDMS casting using a pre-
aligned cover plate containing injection reservoirs (ii) for the introduction of the PDMS 
prepolymer (PDMS + Curing agent at 10:1 ratio) (iii).The PDMS stencil was peeled from 
the mold after curing at 70oC for 90 min (iv) and placed on the surface of a PMMA sheet 
containing a pre-fabricated waveguide channel (waveguide channel was embossed 
from a mold master fabricated using high precision micromilling), the injection reservoir 
and prism recess for launching light into the waveguide were aligned with respect to the 
waveguide channel (v). The COC melt (prepared using toluene as a solvent) was 
introduced through the reservoir to fill the entire waveguide channel and the prism 
recess (vi). This created the embedded waveguide with the monolithic prism in a single 
casting step (vii). The waveguide assembly was further integrated to multiple fluidic 
channels (viii) that were prepared using hot embossing into PMMA. The fluidic substrate 
and PMMA sheet containing the waveguide, which served as the cover plate for the 
fluidic network, were thermally fusion bonded at approximately 105oC, near the Tg of the 
polymeric materials. (b) Photographs of the PMMA sheet showing the embedded 
waveguide (i) with the integrated monolithic prism (to the right is the SEM of a section of 
the prism). (c) Photograph of the OFC waveguide (i) showing the fiber-coupling point (to 
the right is an optical micrograph of the coupling site) and the optical fiber (ii). Continued 













Figure 3.2 (b and c) see caption above 
 
access reservoir to fill the waveguide-defining channel, which spanned a length of 3 cm. 
This assembly was placed on a dry glass plate and allowed to cure in a vacuum oven 
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for 24 h. At the end of the curing period, the PDMS stencil was carefully peeled from the 
PMMA sheet to obtain the optical-fiber-coupled COC core embedded waveguide (see 
Figure 3.2c).  
3.2.6 Integration of the Embedded Waveguide with the Multi-channel Substrate  
The fluidic channels were replicated into a PMMA substrate (thickness = 250 µm) 
via hot embossing from a brass mold master, which was fabricated by high precision 
micromilling.54,55  This PMMA wafer contained channels with dimensions of 100 µm 
width x 30 µm depth and was thermally fusion bonded to the waveguide-bearing PMMA 
sheet in an orthogonal configuration with the waveguide spanning the length of the 
entire array of fluidic channels. In this case, the PMMA sheet containing the embedded 
waveguide served as the cover plate for the fluidic network and also defined the 
illumination cross sectional area for each fluidic channel. Figure 3.3a shows an optical 
micrograph of the waveguide and the fluidic channel when thermally assembled. 
3.2.7 Coupling of Light into the Waveguide  
To minimize light lose at the entrance to the waveguide, a collimated laser beam 
was passed through a beam expander that was used in the reverse mode to reduce the 
beam diameter from 2 mm to ~200 µm. The resulting beam was launched through the 
monolithic prism into the waveguide with a launch angle adjusted to 76o (critical angle θc 
= 75o) using a goniometer. The critical angle here (θc = sine-11.48/1.53) was defined by 
the refractive indices of the PMMA cladding (n = 1.48) and the COC core (n = 1.53). 
In the case of the OFC waveguide, the laser light was first coupled into an optical 











Figure 3.3 (a) Optical micrograph of the embedded waveguide integrated to the fluidic 
channels. (b) Schematic representation of laser coupling into the OFC waveguide. The 
light was first coupled into an optical fiber (labeled 1), followed by another coupling to 
the second optical fiber (labeled 2, which is the fiber coupled to the waveguide) using a 
fiber-fiber coupler, which send the input light to the waveguide. (c) The photograph 
shows the guiding of light (532 nm) through the length of the waveguide (i) when an 
optical fiber was used to couple light into the waveguide; and the scattering of the light 
when there was poor coupling between the optical fiber and waveguide (ii). Continued 












Figure 3.3 (c) See caption above 
 
This generated continuous guiding of the light through the waveguide. To demonstrate 
the waveguiding capabilities of the OFC waveguide, a 532 nm laser (20 mW) was 
coupled into the optical fiber. In Figure 3.3c is shown a photograph of the OFC 
waveguide with the 532 nm laser coupled into it (i). The bottom panel of Figure 3.3c (ii) 
shows an optical micrograph of the waveguide with the optical fiber not properly coupled 
to the waveguide (air space between waveguide and optical fiber). The emerging bright 
laser spot in Figure 3.3c (top panel) is a clear indication of continuous light guiding 
through the waveguide, whereas the unguided laser (bottom panel) resulted in 
significant amounts of scattered light at the optical fiber tip, which indicated improper 
coupling to the waveguide. 
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3.3  Results and Discussion 
3.3.1 Evaluation and Characterization of the Embedded COC Waveguide 
To confirm that loading of the waveguide channel with the COC melt generated 
an optically homogeneous interface between the COC core and PMMA after curing of 
the COC, a scanning electron micrograph (SEM) of the empty waveguide channel and 
the COC filled channel were obtained (data not shown). In addition, we also inspected 
the COC core for inhomogeneity, for example resulting from air bubbles that may create 
speckle patterns in the waveguide due to refractive index changes.  Close examination 
revealed a highly uniform interface between the COC/PMMA waveguide with no 
imperfections at the top of the COC core. These results were further supported by AFM 
images (see Figure 3.4) of the surface of the embedded waveguide. As can be seen in 
this image, the COC core surface was very smooth showing no evidence of large pits 
arising from air bubbles or other materials during its production, which could generate 
light propagation losses.  
a      b 
RMS = 61.248 nm
X = 20.00 µm/div
Y = 4104 nm/div
 
Figure 3.4 (a) AFM image of the surface of the cured COC planar polymer waveguide 
embedded in sheet PMMA; z-scale is 4104 nm/div., x-scale is 20 µm/div. (b) Section 































Figure 3.5 (a) Optical transmission spectra (600 nm – 900 nm) of COC (black), cured 
COC waveguide (red), PMMA (blue), PC (green) and PDMS (purple). (b) Moisture 
resistance of COC compared to other polymer waveguide materials. 
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Amongst the properties of waveguides that defines their suitability for efficient 
light transmission is their optical transmittance at different wavelengths. This is 
particularly important for fluorescence applications, because transmission losses not 
only introduces propagation losses, but can also give rise to autofluorescence that can 
degrade the signal-to-noise ratio in any sensitive fluorescence measurement.35 
Therefore, optical transmission spectra were collected between 600 and 900 nm for 
both the COC sheet and the cured COC core waveguide material using Ultrospec 4000 
UV/VIS Spectrophotometer. A comparison of the optical transmission properties were 
made for other potential polymeric waveguiding materials, such as PC, PMMA, and 
PDMS. As can be seen in Figure 3.5a, COC showed high optical transparency of ~91% 
across the wavelength range scanned, which compared favorably with those of PMMA, 
PC and PDMS. In addition, there was no significant difference in the transmission 
spectrum obtained for a COC sheet and the cured COC waveguide.  
Water absorption is also a critical issue in selecting proper waveguide materials 
because water absorption can change the refractive index of the waveguide material 
inducing light loss or specularly scattered radiation increasing the background in the 
fluorescence measurement.  Therefore, an investigation of the moisture resistance of 
the embedded COC core waveguide was carried out.  A portion of the COC melt was 
coated onto a glass slide to a thickness of 200 µm and cured as discussed earlier. Films 
of other polymers were also made in a similar fashion but using a solvent in which each 
particular polymer showed high solubility. The polymer films were heated to 95oC for 50 
min and subsequently weighed. The sample was then immersed into water for 24 h at 
room temperature and re-weighed following drying under a constant flow of N2 to 
remove surface moisture. The difference in weight was calculated in order to establish 
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the percentage of water absorption.50 Figure 3.5b shows the water absorption 
characteristics of COC and other polymer films with COC giving the highest moisture 
resistance. This result could be related to the more hydrophobic nature of COC, 
compared to the other materials.  
 Another important optical characteristic of waveguides is their transmission 
efficiency as a function of waveguide length.  We measured light attenuation in decibels 
(dB) per unit length (cm) using the equation below; 
 
    A = -10log (Pout/Pin) x 1/L   (3.1) 
 
where A is the attenuation in decibels (dB), Pin is the input laser power (in mW), Pout is 
the output power (in mW) and L is the length of the waveguide (cm). Light was launched 
into the waveguide (launch angle = 76o) near the critical angle (to maximize the 
penetration depth) when a plain PMMA sheet (n = 1.48) was thermally fusion bonded to 
the COC/PMMA waveguide. Using an input laser power of 4.2 mW, an output power of 
1.3 mW was measured resulting in an attenuation of 1.69 dB/cm. From our observation, 
the actual light loss was primarily from scattering of the exiting beam from the distal end 
of the waveguide before reaching the light sensor.  
3.3.2 Waveguide Functionality  
As mentioned earlier, propagation of light through a planar waveguide generates 
an evanescent electromagnetic field, which penetrates into the surrounding medium 
with an amplitude that decays exponentially with distance from the interface. The 
penetration depth (at 1/e intensity) of the evanescent field is estimated with respect to 
the launch angle using the following expression;56 
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           (3.2) 
 
where θ is the launch angle, n1 is the refractive index of the waveguide and n2 is the 
refractive index of the medium (cladding). For example, if the laser light (λ = 635 nm) is 
launched at 760, which is near the critical angle of the waveguide system (n for COC = 
1.53, n for PMMA = 1.48), the corresponding penetration depth is ~870 nm, whereas if 
the launch angle is increased by 10, the corresponding penetration depth is only 564 
nm. Therefore, the appropriate launch angle must be selected in order to obtain the 
maximum penetration depth of the evanescent field into the adjacent solution layer to 
maximize the amount of sample excited by the evanescent field.  
We evaluated the ability of our embedded polymer waveguide for fluorescence 
excitation into the adjacent solution by depositing 20 µL of a 1 µM solution of AlexaFluor 
647 on the embedded waveguide and placing a thin cover slip on the surface to provide 
a uniform thickness of fluid above the waveguide. A 635 nm laser was launched into the 
embedded waveguide through the prism and fluorescent signals were collected at 
different launch angles using a 2x microscope objective to image the entire length (3 
cm) of the waveguide  onto a CCD camera (exposure time = 1 s).  Figure 3.6a shows a 
plot of the fluorescence intensity as a function of launch angle.  As can be seen, the 
highest fluorescence intensity was obtained at a launch angle of 76o, which is close to 
the critical angle of this waveguide. This is expected based on equation 3.2, which 
corresponds to the maximum penetration depth of the evanescent field into the 
adjoining solution layer.  
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To test the ability to generate evanescent excitation with the OFC embedded 
waveguide, laser light (635 nm) was coupled into the optical fiber that fed the COC 
embedded waveguide. The same Alexafluor 647 solution was sandwiched between the 
waveguide and cover slip as described above. Figure 3.6b shows a typical fluorescence 
image acquired with the CCD using the OFC waveguide (CCD exposure time = 1 
s).These results demonstrate the utility of the OFC waveguide for fluorescence 
measurements without beam shaping optics and careful launch angle adjustments, 
which are required for prism coupling.  
The ability to utilize the waveguide and fluidic architecture after assenbly for 
fluorescence measurements in a multi-channel format was also demonstrated by filling 
the fluidic channels (see Figure 3.3a) with a 100 nM solution of AlexaFluor 647 and 
reading the fluorescence signal from each fluidic channel using the CCD with a 10x 
relay objective (NA = 0.5), the results of which are shown in Figure 3.7.  
  In Figure 3.7a, the fluorescence image from eleven (11) parallel microchannels 
(100 µm wide x 30 µm deep with a 100 µm pitch) is shown with a clear demarcation 
between the dye-filled channels (fluorescence signal present with a fairly uniform 
intensity) and the inter-channel space showing negligible fluorescence signal. To clearly 
visualize the waveguide geometry while collecting fluorescence from the fluidic 
channels, a low magnification objective (2x, NA = 0.1) was used to acquire a second 
image. Figure 3.7b gives the fluorescence image from each fluidic channel with the 
region outside the waveguide region showing a dark background. This indicated that 






























Figure 3.6 (a) Top pane is a typical fluorescence image acquired with CCD when light 
was launched into the waveguide with fluorescence solution sandwiched on the surface. 
Bottom pane is the plot of fluorescence intensity at different launch angles. (b) Typical 
fluorescence image acquired with CCD when laser (light) was coupled into the OFC 











Figure 3.7(a) Fluorescence image acquired from multiple fluidic channels (11 micro-
channels shown) filled with 100 nM AlexaFluor 647 when light was launched into the 
COC core embedded waveguide through the monolithic prism; there was a clear 
distinction between channels (with sample) showing fluorescence signal with fairly 
uniform intensity ( bottom pane) and inter-channel spacing showing dark background, 
image was acquired with a 10x microscope objective (NA = 0.5) (b) Fluorescence image 
from the same device acquired with a 2x microscope objective (NA = 0.1) to clearly 
reveal the waveguide geometry.  
 
3.4 Conclusion 
       We have fabricated and evaluated a novel COC core waveguide embedded in 
PMMA that was situated orthogonal to multiple fluidic channels along the width of a 
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PMMA wafer. This design allowed for fluorescence detection from multiple fluidic 
channels using evanescent excitation and a CCD camera for parallel readout. We have 
presented and evaluated two methods of launching light into the embedded waveguide; 
the use of monolithic prism for effective laser launch into the waveguide and the use of 
an optical fiber coupled to the waveguide. The two designs generated an evanescent 
field for the wide field excitation of fluorescent dyes traveling above the waveguide in 
fluidic channels, which enabled reading fluorescence signal from multiple fluidic 
channels in a parallel format. This technology may be particularly attractive for high 
throughput or multiplexed sample analyses. In the near future, the waveguide system 
will be integrated to a high density fluidic network possessing multiple vias for high 
throughput screening of biochemical reactions for drug discovery applications. 
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POLYMER-BASED DENSE FLUIDIC NETWORK FOR HIGH THROUGHPUT 
SCREENING WITH ULTRASENSITIVE FLUORESCENCE 
 
4.1  Introduction 
High Throughput Screening (HTS) is the process of selecting a potential drug 
candidate from a pool of diverse chemical elements, and it represents an integral part of 
the drug discovery process, which is constantly desiring  improved efficiency by 
emerging scientific advances and increasing pressure to reduce drug development 
cost.1-5 The number of potential therapeutic targets are rapidly increasing due to a better 
understanding of the genetic basis of disease. Also, combinatorial chemical synthesis 
has generated large compound libraries for screening against the growing number of 
targets. These advancements have placed high demand on drug discovery screening 
technologies to provide a suitable platform/system that will enhance throughput in the 
screening process. Such screening systems must be able to sustain assay processing 
rates of several thousands per run without sacrificing data quality. In addition, screening 
platforms must be robust and reliable, cost-effective, simple and user-friendly, and 
should be amenable to rapid implementation, standardization and automation to provide 
competitive advantages for the operator.6  
The primary approach toward providing for this demand and to shorten the time 
scale for all aspects of drug discovery has been the adoption of high-density plate 
systems characterized by small well volumes capable of screening ~100,000 assays per 
day.3,7-9 These systems require sophisticated and highly sensitive detection techniques 
to generate high quality assay results due to the small well volume. To provide for this 
sensitivity requirement, fluorescence-based detection techniques have become 
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increasingly popular in designing miniaturized HTS system due to the inherent 
sensitivity advantage of fluorescence measurements.  For example, Modern HTS 
technology, such as the Evotec robotic micro-plate systems (EVOscreen Mark-II and 
EVOscreen Mark-III)10 employs confocal fluorescence readers to serially address assay 
results, and are capable of screening over 100,000 assays/day.10-12 Unfortunately, the 
serial strategy associated with the confocal fluorescence scanner places a severe 
limitation on the capability of the system to enhance assay throughput. Furthermore, the 
implementation of higher density micro-plates with reduced well volumes is faced with a 
number of other hurdles. These include, evaporation problems resulting from the high 
surface-to-volume ratio (i.e. quick evaporation of dispensed liquid), and the 
sophistication required for liquid dispensing. Although, some of these challenges can be 
addressed through concerted efforts in engineering of automated micro-plate 
workstations for HTS (e.g. the Evotec second generation screening platform, 
EVOscreen Mark-III, which utilizes four parallel confocal readers in four detection 
channels),10 it comes with enormous price tags, which could be up to several millions of 
dollars. 
Advances in microfabrication technology has created opportunities for exploring the 
potential of microfluidics for HTS.13 These microfabricated devices are capable of 
manipulating and processing miniature volumes (10-9 to 10-18 Liter) of fluids in 
microchannels with dimensions of a few micrometers, which makes them suitable for 
performing continuous flow assays in a miniaturized format. In addition, several 
processing units can be configured in a small footprint suitable for optical imaging, 
which provides the opportunity for massively parallel experimentation. Furthermore, 
microfluidic devices are characterized by their small size and employ hydrodynamic 
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pressures or electrokinetic pumping for fluid transportation (fluidflow),14-18 which 
facilitates integration to sample detection systems without complex engineering designs. 
These unique features of microfluidics  make  them viable platforms for HTS.19,20 
Employing microfluidics for HTS technology provides several other advantages, 
including, reduction in solvent evaporation problems associated with micro-plates,21 low 
consumption of samples and reagents, short time of analysis and the ability to automate 
fluid handling.22-25 Another key feature of microfluidics is the ability to integrate several 
processing steps into a single system, which simplifies routine operations and also 
eliminates sample cross-contamination. For example, it can integrate functions such as 
sampling, sample transport, biochemical reactions, analyte separation, product isolation 
and detection within a microchannel network.26-28 Consequently,  microfluidics provides 
the ability for serial sample processing and analysis in a single fluidic element and in 
addition, can accomplish massive parallelization brought about by the configuration of 
multiple processors in a single device.29  
The utility of microfluidics for throughput enhancement in different types of assays 
have been demonstrated.30-35 The potential of microfluidics for large-scale biochemical 
screening was demonstrated through the use of microfabricated microchannel array 
systems with automatic sample loading from microtiter plates, to screen 96 samples in 
less than 90 s.36 Other examples of reports that employed microfluidics for high 
throughput assays includes on-chip immunoassays for screening fluorescently labeled 
antibodies,37 continuous-flow sandwich hybridization assay for pathogen detection,38  
integrated microfluidics and bead-based assays for high throughput detection of gene 
expression,39 detection of low-affinity transient binding events in biomolecular 
interactions,40 parallel screening of in-situ click chemistry,41  kinase assays based on 
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separation of reaction products from substrates and cell-based assays.3,42-44 Therefore, 
the application of microfluidics in HTS can provide a way to resolve current challenges 
in drug screening and significantly increase throughput with minimal operation cost in 
drug discovery projects.29  
Fabrication of microfluidic devices have been traditionally done in glass and silicon 
using technology borrowed from the microelectronics sector.45,46 The attractiveness of 
glass as materials for microfluidic fabrication includes their well-defined surface 
chemistry, and good electroosmotic properties, which make them compatible with many 
biochemical and flow-based assays.  Also, the excellent optical properties of glass 
make them suitable for ultra-sensitive fluorescence measurements. However, the 
fabrication modalities are time-consuming, challenging and relatively expensive.  
Polymers offer important advantages and have attracted much interest in 
microfluidic device production due to their simple fabrication characteristics, and in 
some cases their favorable optical properties. In addition, they are generally low-cost 
materials, which allows for inexpensive mass production of microfluidic devices.47  
While microfluidics provide a suitable platform for HTS by generating high number of 
sample processing units over a small footprint, a suitable detection system is required 
for parallel interrogation of the fluidic processors using wide-field illumination, such that 
the resulting fluorescence is imaged onto an array detector possessing the prerequisite 
sensitivity for parallel readout. An array detector that can be employed for ultra-sensitive 
fluorescence detection is the electron multiplying charge-coupled device (EMCCD) with 
frame transfer capabilities to provide for high speed imaging in near video frame rates, 
which allows monitoring of biochemical reactions with high efficiency.48-50 Throughput in 
this case is directly related to the number of fluidic processors that can be imaged onto 
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the detector; therefore, the configuration of the fluidic processors in a high density 
format is important to provide increased throughput and to realize the full potential of 
microfluidics in HTS.51 
In this Chapter, we present a high density fluidic device with a series of individual 
sample processors configured in a small footprint suitable for optical imaging. The 
device was fabricated using UV-LiGA to first produce the required fluidic structures on a 
metal mold (Ni mold master), which was transferred onto a polymer substrate during 
replication. The polymer microchip possessed multiple fluidic processors with an 
individual input reservoir. An ultrasensitive fluorescence detection system with a large 
field-of-view (FoV) was used to transduce fluorescence signals simultaneously from 
each fluidic processor onto the active area of an EMCCD. The utility of the multichannel 
network for HTS with an optical system for providing the prerequisite sensitivity was 
demonstrated by parallel monitoring of fluorescence signal from AlexaFluor 660 labeled 
oligonucleotides that were hydrodynamically pumped through individual fluidic channels. 
Evaluation of the fluidic system using blank and dye samples indicated the absence of 
cross talk between fluidic channels, and thus, indicating the apparent capability for 
simultaneous monitoring of multiple biochemical assays as appropriate for HTS.  
4.2  Experimental Procedure 
4.2.1 Fabrication of the Fluidic Network 
The fluidic structures were fabricated using UV-LiGA to produce Ni electroforms 
(mold master) according to standard lithography procedures already reported (see also 
Chapter 1, Section 1.4.2).52, 53 To achieve a precise depth of 1 μm for the fluidic 
channels, SU-8 photoresist was spin coated (3500 rpm; 30 s) on a silicon disc to a 
thickness of 1 μm and baked for 1 min at 95oC on a hot plate. A UV mask containing the  
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Figure 4.1 The design of the UV mask containing the fluidic patterns. Three different 
patterns were poised on the mask; from top to bottom. 10 μm wide (pitch = 10 μm), 5 
μm wide (pitch = 2 μm) and 1 μm wide (pitch = 1 μm) patterns. 
 
fluidic patterns was designed (see Figure 4.1) and used for the UV exposure prior to 
development and electroplating steps to make the master mold. The UV mask (see 
Figure 4.1) consisted of three different device designs: (1) a 10 μm width (pitch = 10 
μm), (2) a 5 μm width ( pitch = 2 μm) and (3) a 1 μm width (pitch = 1 μm) patterns, that 
could be used interchangeably to make any of the three different structures (See Qu et 
al. for specific details on UV-LiGA procedures52). Hot embossing was used in the 
molding step to transfer the fluidic pattern from the mold master onto PMMA substrates 
by employing a JenOptik HEX02 high-precision hot embossing system to create high 
fidelity in the features over large areas. The fluidic architecture of the high density model 
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microchip is shown in Figure 4.2. The device consisted of 25 fluidic processors with 
dimensions of 5 μm width, 1 μm depth and a pitch of 2 μm configured in a footprint of 
~180 μm in the high density region for optical detection. Figures 4.3a and 4.3b present 
SEM images of sections of the molded parts made in PMMA. A PMMA cover plate 
(Thickness = 125 μm) was placed on the device to create the fluidic channels and 
subsequently fusion bonded to the substrate in a GC oven at 107oC (slightly above the 
Tg of PMMA) after being clamped between two glass plates to render uniform pressure 
(see Figure 4.3c). Each fluidic processor possessed an individual sample input reservoir 
(see Figure 4.3b) for introduction of reactants (enzyme and substrate) and also a 
reaction zone equipped with a strip heater for incubation of the enzyme and substrate 
and thermal perturbation of the reaction products (see Figure 4.2). The fluidic channels 
gradually fan-out (see Figure 4.3 a and c) from the high density region to connect with 
the individual sample reservoirs (see Figure 4.3b). The spread of the fluidic channels 
provides two advantages: (1) Each fluidic channel serves as an independent sample 
processor, which allows for multi-sample interrogation; and (2) generation of adequate 
reaction zone (reactors) with sufficient room for incubating enzyme and substrate (see 
Figure 4.2) via integration with small heating elements, such as a strip heater to supply 
thermal energy to the fluidic processors without negatively impacting the fidelity of the  
fluidic channels. The width of the channel is 22 μm at each individual reservoir (see 
Figure 4.3b) and tapers to 14 μm at the reaction zone (see Figure 4.3a) and then to 5 
μm at the high density (detection) region. All fluidic processors have equal lengths (3 
cm) and equal depths (1 μm) from the sample input reservoir to the common reservoir. 
This was important to maintain uniform hydrodynamic pressure in all the fluidic  
processors. The volume capacity of each individual fluidic processor is ~0.15 nL, which     
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Figure 4.2 Schematic of the fluidic network for HTS (1, 2 & 3 are SEMs of a Ni 
electroform related to the indicated sections of the device) possessing reactor channels 
for incubating the enzyme target with the substrate and potential drug inhibitor. The 
dense network of channels for imaging evaluates the efficiency of drug inhibition by 
measuring fluorescent signal. The device has a total of 25 fluidic processors configured 
in a 180 μm wide footprint. 
 
         
Figure 4.3 (a) SEM of a section of the molded device in PMMA using hot embossing. 
The section shown is where the channels spread out to accommodate individual sample 
input reservoirs (b) SEM of one of the channels showing the individual sample input 
reservoir. (c) Optical micrograph of a section of the sealed device showing the geometry 
of the fluidic network. (d) Optical micrograph of the microchip showing the fluidic 
network and the common reservoir. 
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provides advantages in terms of reagents economy. All channels possessed a common 
output reservoir (see Figure 4.3d) for collection of waste following each assay. A replica 
device was also made through the same process but having a width of 10 μm and pitch 
of 10 μm (depth = 1 μm). 
4.2.2 Optical Set-up and Multichannel Illumination 
A wide field-of-view (FoV) fluorescence detection system (details presented in 
Chapter 2) was used to monitor fluorescent signals from the fluidic vias using a highly 
sensitive EMCCD operated in a frame transfer mode. The optical system was 
configured in an epi-illumination format with beam shaping optics and employed a 40x 
microscope objective (Numerical Aperture, NA = 0.75) to generate a collimated light 
output with a diameter of ~200 μm. At this magnification, the system possessed a FoV 
of ~200 μm, which allows interrogation of all 25 fluidic processors simultaneously. The 
system is not limited by magnification of the objective and thus accommodates other 
microscope objectives with the appropriate NA to expand the FoV. For example a 20x 
microscope objective (NA = 0.75) generated a FoV of 400 μm. 
4.2.3 Chemicals and Reagents 
Tris-Taps-EDTA (TTE) buffer was used for all measurements; 1x TTE  buffer 
solution (pH = 8.7) was prepared from a stock solution of the buffer (10x) using 
nanopure water obtained from a Barnstead NANOpure System (Model D8991, 
Dubuque, IA). AlexaFluor 660 was obtained from Molecular Probes (Eugene, Oregon, 
USA) and working solution samples were diluted from a stock solution (80 nM) using 1x 




4.3  Results and Discussion 
4.3.1 Parallel Fluorescence Measurements in the Multichannel Device 
Hydrodynamic pumping was used to drive fluid through the device. This was 
achieved by connecting a syringe pump to the common reservoir while each fluidic 
channel fed with a prepared sample at its appropriate reservoir. The syringe pump was 
operated in the refilling mode, which transported the liquid sample from its reservoir 
through each fluidic channel at a constant flow rate (linear velocity = 0.03 cm/s). Using 
this set-up, a 2.0 nM solution of AlexaFluor 660 was hydrodynamically pumped through 
each fluidic channel of the device and a fluorescent signal was acquired simultaneously 
from all the fluidic processors. Figure 4.4a is a fluorescence image obtained with the 
CCD showing fluorescent signal from all 25 microchannels. With these channel 
dimensions (5 μm width, 2 μm pitch), a 20x objective with the same numerical aperture 
(NA) as the 40x (NA = 0.75) will generate a FoV of 400 μm, which will allow the 
simultaneous fluorescence detection from 50 microchannels. We also investigated 
sample throughput with a 10 μm wide channel (pitch = 10 μm) because it was easier to 
drive fluid through these larger channels due to lower pressure drop.  The fluorophore 
was driven through the fluidic channels in the same manner and fluorescent signal 
measured. Figure 4.4b shows a fluorescence image from 15 microchannels. This 
means that if the 20x objective is used, 30 channels can be imaged using these channel 
dimensions. 
4.3.2 Investigation of Cross Talk Between Channels 
 
To investigate potential cross talk between the fluidic channels, blank samples (buffer) 
and dye samples (AlexaFluor 660) were loaded into the individual sample reservoirs 
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and a fluorescence image was acquired. Figure 4.5a shows an image when some 
channels were loaded with dye and others loaded with buffer. The channels loaded with 
dye gave fluorescent signal while those loaded with the buffer (marked x in Figure 4.5a) 
gave no fluorescent signal. Thus, the system could monitor multiple biochemical assays 
without cross contamination. This was further explicitly indicated by generating a 3D 
image of Figure 4.5a (see Figure 4.5b) to show fluorescent signal profile from channels 




Figure 4.4 (a) CCD image of fluorescent molecules (AlexaFluor 660) migrating through 
the high density chip (channel dimension = 5 μm x 1 μm (pitch = 2 μm). The 
fluorescence was collected with a 40x/0.75 objective using a 200 ms CCD exposure 
time (25-fluidic channels were imaged (b) CCD image acquired using the same 
condition in a wider channel (dimension: 10 μm x 1 μm, pitch = 10 μm); 15 fluidic 
channels were imaged. 
 
 
4.4 Conclusion and Future Work 
A novel microfluidic system was fabricated suitable for high throughput screening of 
combinatorial libraries for a specific target. The fluidic channels were configured in a 
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high density format that could also be optical imaged. We have demonstrated the ability 
to carry out simultaneous fluorescence measurements in multiple fluidic channels, 
which will allow for multiple assays to be analyzed in a massively parallel fashion. Whilst 
                        a 
x x x x x x x x x x x x xx  
                        b 
 
 
Figure 4.5 (a) CCD Image acquired when fluidic channels were filled with buffer or dye 
(AlexaFluor 660) samples; the locations marked ‘x’ are buffer-filled channels. (b) 3D 
image showing the fluorescence intensity profile in channels loaded with AlexaFluor 
660; the channels marked x in (a) appeared as a dark background also in (b) 
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the present fluidic design yielded a theoretical 50-fold increase in sample throughput 
compared to serial strategies for HTS, this throughput can be significantly increased 
simply by reducing the channel width. For example, with a channel width of 1 μm (pitch 
= 1 μm), 100 fluidic processors can be imaged in an ~200 µm field-of-view. Further 
reduction in channel width to 500 nm with a pitch of 500 nm would allow the ability to 
image a total of 200 fluidic processors simultaneously using a 40x microscope objective. 
The introduction of a 20x microscope objective with high numerical aperture (NA = 0.75) 
in this case would generate a throughput of 200-fold for a 1 μm wide channel design 
and 400-fold for the 500 nm channel design. The fluidic device will be further evaluated 
by screening a small library of compounds against a specific target. For example, L1 
endonuclease (L1-EN) is an enzyme responsible for double strand breaks in genomic 
DNA and is associated with 45 different diseases, including aging and cancer.54 Also 
APE1 is another important target which causes radio- and chemo-resistance in human 











Figure 4.6 A pictorial depiction of a model assay for screening a combinatorial library 
for L1-EN and APE1. 
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be screened to register drug candidates for clinical trials.  The pictorial depiction of a 
model screening assay for these targets is shown in Figure 4.6. The small molecule 
inhibitor (drug candidate) will be incubated with the enzyme in the presence of an 
appropriate substrate containing the action site of the enzyme. The substrate (double 
stranded DNA) will be labeled with a fluorophore and a quencher and fluorescence 
monitored with proximity considerations to determine the extent of double strand breaks 
induced by the enzyme activity.  Whilst L1-EN which is a 6-base cutter recognizes 
AATTTT motif, APE1 recognizes the apurinic (AP) site in genomic DNA and these sites 
will be incorporated in the designed substrate for the screening experiments. 
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MICROFLUIDIC DEVICE WITH INTEGRATED CONDUCTIVITY SENSOR FOR 
QUANTITATIVE ENUMERATION OF CIRCULATING TUMOR CELLS (CTCS): AN 
APPROACH TO CLINICAL EVALUATION OF DRUG EFFICACY 
 
5.1  Introduction 
Hematogenous spread of metastatic carcinomas is the reason for most cancer-
related mortalities.1  For Breast cancer, the death rate is estimated to be ~45,000 
deaths per year in women.2  Therefore, intensified research effort is required to develop 
simple techniques that can monitor the effectiveness of cancer therapies, and at the 
same time could support the successful search for suitable therapeutic agents, as well 
as promote early diagnosis of the disease to enhance survival rate of cancer patients. 
Whilst tumors, such as breast cancer have been traditionally diagnosed using a 
combination of radiological, surgical biopsy, as well as pathological assessment of 
tissue samples based on morphological and immunohistochemical characteristics, 
requiring evaluation of tissue samples under a microscope, the process has proved  to 
be invasive and time consuming and is also accompanied with high rates of false 
positive results, which range from 20 – 50%.3,4 A clear understanding of the stages in 
tumor metastases could provide an avenue for developing new tools for early tumor 
diagnosis which will allow for appropriate and timely administration of cancer therapies. 
Classical views envisioned metastasis as a late process in tumor progression; however, 
it has been shown that dissemination of cancer cells to distant organs is an early 
process in tumorigenesis, especially in breast cancer.5-7 There are two main routes for 
cancer cell dissemination to distant organs; these are the bone marrow (BM) and 
peripheral blood of cancer patients. While there is evidence that the BM serves as a 
homing reservoir for tumor cells of many types of carcinomas, the peripheral blood 
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serves as a transportation medium through which distant sites are effectively accessed 
by tumor cells.8-11  This indicates that the number of tumor cells in peripheral blood and 
also in BM can reflect tumor burden at all stages of cancer progression. Therefore, the 
detection and characterization of tumor cells in BM and in circulating peripheral blood 
has gained significant attention in cancer research.12 Disseminated tumor cells (DTCs) 
and circulating tumor cells (CTCs) are two nomenclatures used to describe tumor cells 
in bone marrow and peripheral blood, respectively, and both present clinical significance 
in cancer management.9    
Quantitative assessment of DTCs and CTCs can facilitate early detection of 
cancer and its successful treatment, as well as indicating survival probability of cancer 
patients.13 In addition, it can be used for real-time monitoring of systemic anticancer 
therapies in clinical management of several cancer-related diseases to provide 
information such as the success or failure of therapeutic agents.14  Furthermore, it can 
serve as an indicator to guide the development and clinical evaluation of new cancer 
drugs,12,15,16  for example in the search for suitable therapeutic agents for L1-
Endonuclease and APE1 (see chapter 3).  
Although, the detection of DTCs in BM has been hypothesized to be of superior 
clinical significance compared to CTCs in blood,17,18  sampling BM for DTCs 
enumeration during routine procedures in clinical management of cancer patients is 
invasive, time consuming, and uncomfortable for the patients. Moreover, sampling 
modality of BM is difficult to perform in certain situations, such as during control visits at 
outpatient centers, which can hamper repeated analysis. As a result, efforts have been 
concentrated on CTC enumeration in peripheral blood,12,19 which has also assumed a 
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leading role in cases such as gastrointerstinal cancer, where dissemination of cancer 
cells to BM is rare.20  
The major challenge with quantitative enumeration of CTCs is the ability to make 
determination of the extremely low abundance of these cells among high numbers of 
co-existing cells, such as erythrocytes and leukocytes. For example, 1 mL of whole 
blood may harbor < 10 CTCs but have >109 erythrocytes and >106 leukocytes.13  
  There are two main approaches to CTC detection; these are, immunological 
assays (immunocytochemistry) that employ monoclonal antibodies directed against 
certain membrane protein targets specifically expressed in cancer cells (e.g. 
cytokeratins), and the other being PCR-based molecular assays, such as reverse 
transcriptase (RT)-PCR and quantitative PCR (qPCR), which target tissue specific gene 
expression,21-23 and utilize detection methods, such as fluorescence in-situ hybridization 
(FISH) to identify gene aberrations and measure tumor-associated gene expression.24 
Unfortunately, these methods are usually preceded by an enrichment procedure, such 
as immunomagnetic bead techniques,25,26 and are associated with poor quantitative 
results,27 long preparation times, expensive experimental equipment and lack of 
methodological standardization. Thus, developing CTC detection methods that are more 
sensitive, and highly reproducible are still required.  
 Several research findings have shown that cells of different types or in distinct 
biological states have different dielectric properties,28-30 and this difference in dielectric 
nature has been used to select certain biological cells from mixed populations based on 
differential dielectrophoretic (DEP) forces.31-33 Wang et al.34  used this principle in 
combination with field-flow-fractionation to separate human breast cancer cells from T-
lymphocytes and hematopoietic stem cells. Becker et al.35 also demonstrated that the 
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dielectric properties of metastatic human breast cancer cells are significantly different 
from those of erythrocytes and T-lymphocytes, and they used a dielectric affinity column 
to remove tumor cells from dilute blood. These approaches are based on the fact that 
biological cells become electrically polarized when subjected to an alternating electric 
field,31 and the degree of polarization of these  cells depends strongly on their 
composition, morphology, and phenotype and is also highly dependent on the frequency 
of the applied electrical field, thereby enabling the selection of these cells.36 This results 
in cells of different types and in different physiological states having distinctly different 
dielectric properties. 37 
Information secured from electrical impedance spectroscopy (EIS) techniques 
opened up another venue for characterizing biological cells based on their electrical 
properties.38-40 Han et al.3 employed micro-impedance spectroscopy (µ-EIS) to 
discriminate human breast cancer cell lines of different pathological stages from normal 
human breast tissue cell lines.  
While µ-EIS and DEP have been widely employed for cell characterization, they 
are not adept at selecting rare tumor cells from mixed populations due to the low 
throughput of these sampling techniques.  Therefore, a more reliable method that 
provides   high-speed quantitative detection and enumeration of cancer cells is needed. 
For example, simple electrical conductivity measurements can be configured in high 
flow rate systems to transduce cellular and molecular species traveling through an 
electrode pair. This was demonstrated by Galloway et al.41 and McWhorter et al.42 in the 
analysis of mono- and poly-anionic molecules and in the detection of polymerase chain 
reaction products.   
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The fundamental morphology of tumor cells indicates that they possess very low 
membrane potential and low impedance, resulting from the migration of the extracellular 
sodium  ion (Na+) in compensation for the depleted potassium ion concentration (K+) of 
the intracellular fluid.43,44 Consequently, these cells are characterized with high 
intracellular Na+ concentration.44 This sustained elevation of intracellular sodium acts as 
a mitotic trigger causing cells to divide rapidly.45 In the resting phase, normal cells 
maintain a high membrane potential at around 60 mV to 100 mV, but when mitosis and 
DNA synthesis begin, the membrane potential falls to around 15 mV.46 Thus, an 
increased rate of cell division associated with tumor cells constantly keeps them at a 
low membrane potential. In addition, tumor cells have different lipid and sterol contents 
in their membrane when compared to normal cells.47  This altered membrane 
composition disrupts the membrane permeability, which results in the movement of 
potassium, magnesium and calcium out of the cell while accumulating sodium and 
water in the cell.48 Also, the alteration in the cell membrane content with respect to the 
types of glycoproteins and antigens that tumor cells express result in an increase in the 
number of negatively charged sialic acid molecules that cap the tips of glycoproteins 
and glycolipids that extend outward from the cell membrane.49,50 The inability of tumor 
cells to produce cellular energy: adenosine tri-phosphate (ATP) is another factor 
responsible for the high rate of transmembrane movement of the mineral contents of the 
cell.  A steady supply of cellular energy is required to maintain a normal concentration of 
intracellular minerals and a healthy membrane potential. These phenomena, which 
result in changes in the mineral contents of the cell, increase the intracellular 
concentration of positively-charged sodium ions and also generate an increase in 
negative charges on the cell coat (glycocalyx),51,52 which are the major factors causing 
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cancer cells to have lower membrane potentials compared to healthy cells.53 This 
makes tumor cells highly conductive amidst normal erythrocytes and leukocytes, thus 
prompting the design of appropriate conductivity systems for their selective 
quantification.  
Conductivity detection is an electrochemical technique with the ability of 
detecting small changes in ionic composition of tiny amount of solution, which could 
result from the presence of minute species in a miniaturized system and thus, has found 
utility in micro-fluidic applications,41,42,54 in which fluidic channels can be configured to 
closely parallel the size of molecular species. The effectiveness of this detection 
technique is highly dependent  on the electronic design of the conductivity system to 
provide  optimal sensitivity appropriate for interrogating single cells, such as CTCs.55,56 
The conductivity response (G) is defined with the following expression:  
 
G = (λ+ + λ-)C/1000K                 (5.1) 
 
where λ+ and λ- (S cm2 equiv-1; S = Siemens) are the limiting ionic conductances of 
cations and anions in solution, C is the solution concentration and K is the cell constant 
(K = L/A, where L is the distance between the electrode pair and A is the area of the 
electrode). Reducing the spacing between the electrodes and/or increasing the area of 
the electrodes will increase the magnitude of G (by reducing K) and consequently 
improve the detection limit of the conductivity measurement. 
In this study, we designed a simple but very sensitive microfluidic-based 
conductivity detection system, which was constructed with platinum (Pt) wires that were 
integrated into a PMMA-based microfluidic device fabricated by hot-embossing and high 
precision micromilling. The fluidic channel and the cell constant (defined by the 
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electrode geometry) were carefully scaled to nearly parallel the size of tumor cells. The 
detection system demonstrated high efficiency enumeration of tumor cells in seeded 
samples that were hydrodynamically transported through the fluidic channels and the 
electrode pair.  Smaller cells with different electrical properties, such as red blood cells, 
were not detected using the present conductivity cell configuration due to low signal-to-
noise ratio for this cell type. The ability of the detection system to selectively detect 
CTCs in blood samples was demonstrated via its integration with a microfluidic-based, 
high throughput micro sampling unit for CTC isolation and subsequent label-free 
enumeration without interference from erythrocytes and leucocytes.  
5.2  Experimental 
5.2.1 Reagents and Materials 
Human breast cancer cell line, MCF-7 was used as a model for CTC detection 
which was studied along with other co-existing cells in blood: the white blood cells 
(WBC) and red blood cells (RBC). The Jurkad E6 cell line was used as a model for 
white blood cells in this study. 
MCF-7 and WBC were purchased from ATCC cultures, USA. RBC, 
tris(hydroxylmethyl)aminomethane (TRIS), glycine, trypsin (proteomic grade) and 
Tween-20 detergent were purchased from SIGMA ALDRICH, USA. The measurement 
buffer was prepared from TRIS, glycine and Tween-20 detergent using nanopure water 
obtained from a Barnstead NANOpure system (Model D8991, Dubuque, IA). 
5.2.2 Microscopy  
Axiovat 200M (Zeiss) fitted with a CCD video camera (JAI CV 252) was used for 
cell visualization and to acquire real time video microscopy information during 
conductivity measurement. The video camera was operated at a frame rate of 30 fps. 
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5.2.3 Cell Culturing and Sample Preparation 
 MCF-7 cells were cultured in Dubelco modified Eagle’s medium for 2 days at 
37oC, then harvested using 0.25% trypsin and resuspended in the same medium. Prior 
to conductivity measurements, a portion of the cell suspension was centrifuged for 2 
min at 300 rcf, then washed twice with Tris-glycine buffer (0.18 mM Tris, 47 mM Glycine 
and 0.05 % Tween 20) to completely eliminate residual growth medium. The resulting 
cells were re-suspended in the same buffer and counted using a hemocytometer to 
obtain working samples. WBCs were grown under the same condition as those used for 
MCF-7 cells, harvested from the culture plate with slight agitation and re-suspended in 
the measurement buffer (Tris-glycine buffer with Tween-20) from which working 
samples were obtained as described earlier. A suspension of the RBCs (0.3 mL) was 
centrifuged and washed in the buffer (Tris-glycine, Tween-20), then re-suspended in the 
same buffer  to obtain a stock sample from which dilutions were made and  counted 
with the hemocytometer to obtain the required cell density. 
5.2.4 Design of the Conductivity Detector 
  The design and electronic layout of the conductivity detector is shown in Figure 
5.1. To reduce the effects of parasitic capacitance, Cp, due to wiring and electrode 
configuration, a synthetic inductor, L, of 132 mH was designed using a Gyrator circuit. 
Gyrators, for a given bandwidth, allow the creation of a high quality factor (Q) of 
inductors from resistance and capacitance (RC) components. Q is defined as; 
 
Q = ωL/R                                (5.2) 
 
where ω is the angular frequency and R is the series resistance of the inductor, which 
represents energy lost by the inductor;  Inductors of the size and Q needed would be 
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impossible to construct utilizing coils wound on ferrite materials. This inductance was 
placed in parallel with the capacitance Cp (produced by the electrical wiring), and the 
frequency varied to locate the resonance voltage across L and Cp. Once this resonance 
point was found, the voltage across the sample cell would be directly sensitive to 
changes in the solution conductivity, Gs. The equation for the impedance of the 
equivalent circuit consisting of the sample cell in parallel with the inductor is a third-
order polynomial that makes the analytical determination of impedance difficult. But for 
typical circuit values near resonance, the absolute value of impedance is approximated 
with the expression: 
 
    /Z/= 1/Gs                                                  (5.3) 
 
 
where /Z/ is the absolute value of the impedance. The sine wave generator produced a 
waveform that could be adjusted from 0 to ±1 V in amplitude and 25–50 kHz in 
frequency.  A target frequency of 40 kHz was chosen to minimize the impedance due to 
the double layer capacitance, Cd, and also hold the inductance to a reasonable value. 
This signal was fed to a transconductance amplifier, G1, which converted the sinusoidal 
voltage to a current. The gain of G1 was set to 10 µA/V. A current source was needed to 
drive the sample cell since a voltage source, with its low output impedance, would 
negatively impact the circuit’s Q. For the experiments performed in this study, the 
current was set to ±5 µA. The required resonance frequency (f) could be approximated 
by the standard parallel resonance equation;  
 





Figure 5.1 Electronic circuit diagram of the detector system. The bipolar waveform 
(±0.5V) was supplied by the sine wave oscillator, which was converted to AC current 
(±5µA) by the transconductance amplifier. The inductor L (132mH) was configured 
parallel to the sample equivalent circuit to cancel out the effect of parasitic capacitance 
Cp. The phase adjust was used to compensate for delay signal through the sample cell 
while the AD630 delivers phase synchronized signal through the low pass filter (180 Hz) 
and offset filter to the amplifier. 
 
The voltage across the sample cell was fed to an analog device (AD630 synchronous 
modulator/demodulator, Norwood, MA) that was configured as a phase-sensitive 
detector. The AD630’s reference input was driven from the phase-delayed sine wave 
oscillator output. This phase adjustment was needed to compensate for phase lags in 
the detected sample voltage. This voltage was then fed to a low-pass filter with a cut-off 
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was sent to a differencing amplifier, A1. The difference amplifier serves to null the output 
to 0 V, such that any output other than 0 V provided, will be due solely to changes in the 
solution capacitance. A high gain amplifier, A2, could amplify small changes in solution 
conductivity without saturation of the voltage produced by the buffer itself.  A National 
Instruments PCI6071E, 12 bit A/D acquisition card was used to convert the analog 
signal to 12-bit data. 
5.2.5 Fabrication of the Microfluidic Device with Integrated Electrodes for 
Conductivity Detection 
 
Figure 5.2A shows the design of the microfluidic device with integrated Pt electrodes. 
The device was fabricated by a combination of hot embossing and high precision micro-
milling as outlined in Figure 5.2B. The Pt wire (76 μm) was perfectly positioned on the 
surface of a PMMA wafer and tacked down at both ends with transparent adhesive tape 
(see Figure 5.2B). This was followed with embossing of the wire into the PMMA wafer 
using hot embossing technology (1200 psi for 4 min at 160oC). Prior to micro-milling, the 
PMMA chip with embossed Pt wire was flattened in a GC oven at 107oC for 12 min after 
being clamped between a pair of glass plates. A microchannel with dimension of 50 µm 
(width) x 80 µm (depth) was then constructed on the PMMA chip by micro-milling across 
the Pt wires to generate a pair of electrodes aligned with the wall of the channel. The 
distance between the electrodes paralleled the width of the channel (50 µm), thus 
generating a cell constant, K = 110 cm-1.  The micro-milled channel with the electrode 
assembly was sonicated for 2 min in water, dried and cleaned in isopropyl alcohol prior 
to being enclosed with a PMMA cover plate (125 µm thick PMMA) by thermal annealing 
at 107oC for 22 min to create the fluidic channel and the integrated Pt electrodes. The 
detection system possessed a probe volume of 226 pL which was adequate to 
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interrogate a single tumor cell traversing the micro electrodes based on size 
consideration. 















Figure 5.2 (a) Optical micrograph of the microfluidic device with integrated Pt 
electrodes. (b) Schematic presentation of the fabrication process for generating the 
microfluidic device with the integrated Pt electrodes. The Pt wire possessed a diameter 
of 76 µm. 
 
5.2.6 Conductivity Measurements 
           All experiments were carried out using Tris-glycine buffer containing 0.18 mM 
Tris, 47 mM glycine and 0.05% vol/vol Tween-20 detergent as earlier mentioned. This 
buffer was chosen due to its very low conductivity (~50 µS/cm, pH 7.2) and the fact that 
it was able to prevent intercellular adhesion and non-specific adsorption of the cells to 
the surfaces of the fluidic chip.  The experimental set-up for the conductivity 
measurement is shown in Figure 5.3. The integrated electrode pair (sensor) was 
connected to the conductivity detection box that housed the conductivity circuit (see 
section 5.2.4) which was used to generate the conductivity signal.   Prior to the 
introduction of cell suspension into the integrated device, the buffer was 
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hydrodynamically pumped through the micro-channel using a syringe pump (see set-up 
in Figure 5.3), and the signal from the buffer was normalized to 0 (see also section 
5.3.1). This was then followed with the cell suspensions (samples) prepared in the same 
buffer, which were hydrodynamically pumped through the channel at different flow rates 
(0.05 µl/min and 0.02 µl/min) in order to measure conductivity changes as single cells 
traversed through the detector. These flow rates were chosen based on the minimum 
sampling time (0.1 s) of the data acquisition software and to allow enough detection 
time (Td) for a single cell traversing the electrodes. This time was calculated to be 0.3 s 
at 0.02 µl/min flow rate and 0.7 s at 0.05 µl/min flow rate. Thus, at higher flow rates, a 
cell spending less than 0.1 s in the detection volume (226 pL) will not be detected, and 
at lower flow rates, there will be peak broadening due to increased Td and consequently 
increasing the length of the experiment. In addition, cell densities were chosen in 
agreement with these flow rates so as to keep the probability (Pc) of finding a single cell 
in the detection volume low (i.e. Pc < 1). 
 
 
Figure 5.3 Schematic presentation of the experiment set-up for conductivity detection of 
cells and visualization with video microscopy. The fluidic channel was connected to the 
syringe pump via a capillary (OD =0.75 µm) and stabilized on a motorized stage of the 
video microscope. The video microscope was operated with a 20x microscope objective 
to acquire image at a frame rate of 30 fps. The electrode pair was connected to the 
detector which supplied the bipolar wave form for interrogating the cells.  
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5.3  Results and Discussion 
5.3.1 Background Stabilization 
The detection system herein reported for single-cell detection was characterized 
with a double-layer capacitance Cd and parasitic capacitance Cp (see Figure 5.1) that 
could generate high background signals which can mask the small signals generated 
from the single cells. To reduce such unwanted interference from the background 
signals, the offset filter (see Figure 1) was adjusted to bring the background signal to 0 
when only buffer was introduced into the microchannel. The low-pass filter (180Hz) was 
used to minimize the random noise resulting from the AC components of the system’s 
electronics to further improve the signal-to-noise ratio. Figure 5.4 shows a background 
adjusted conductivity plot of Tris-glycine buffer pumped through the microchannel. The 
absence of signal perturbations clearly indicates the stability of the generated signal and 
the conductivity electronics. In addition, no evidence of Faradaic reactions can be seen 
from this plot, which would generate “spikes” in the trace due to gas evolution. The 
absence of Faradaic reactions results from the bipolar pulse voltage waveform used at 
a frequency of 40KHz, which prevents double layer formation within the cell.41 
5.3.2 Conductivity Measurement of Cell Suspensions 
 Conductivity measurements were performed using different cell densities and 
various flow rates (0.02 µL/min and 0.05 µL/min).  Figure 5.5 shows the results obtained 
when MCF-7 cells at a concentration of 150 cells/µL (cell suspension prepared in buffer 
and counted with hemocytometer) was hydrodynamically transported through the device 
at a flow rate of 0.02 µL/min. Fifty-eight signals were registered (counted) from the 
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Figure 5.4 Background-adjusted conductivity plot with only the measurement buffer 
(Tris-glycine buffer) contained in microchannel. Experiment conditions used were; 40 
KHz frequency, ±0.5V bipolar voltage, ±5µA alternating current (AC current), and a flow 
rate of 0.02µl/min  
 
representing a single tumor cell as confirmed by video microscopy.  With these values, 
the concentration measured was calculated to be 175 cells/µL, which agrees favorably 
to the input concentration. Figure 5.6 is the result obtained from MCF-7 cells using a 
concentration of 146 cells/µl and a flow rate of 0.05 µL/min. At these conditions, the 
number of cells registered was 122 cells and the total volume processed was 0.83 µL, 
providing a measured cell concentration of 147 cells/µL, again agreeing favorably to 
input concentration. Based on these observations, the detection and sampling efficiency 
of the detection system  was estimated as ~100%. 
 Conductivity signals were verified with video microscopy (see Figure 5.3) 
acquired in real time with the conductivity measurement to confirm that each signal 
resulted from a single tumor cell traversing the electrodes. A video frame image of such 
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real time video acquisition is shown in Figure 5.7. The peak width obtained using 0.05 
µl/min flow rate (see Figure 5.6) appeared smaller than those obtained using  0.02 
µl/min flow rate (see Figure 5.5), which agrees with our expectations due to differences 
in transit time (i.e Td) of the cells in the detection volume at the different flow rates. The 
































































Figure 5.5 Conductivity response from  MCF-7 cells ([cell] = 150 cells/µL) using tris-
glycine buffer as the suspension medium and at a flow rate of 0.02 µl/min. Upper panel 
shows signal obtained over 1000s with a total of 58-cells  registered from the volume 
processed (0.33 μL), the lower panel shows the signal over the first 300s. Experiments 
were run at a sampling time of 0.1s using ±5µA AC current, ±0.5 bipolar voltage, and 
40KHz frequency. 
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these flow rates to keep the probability of finding a single cell in the detection volume 
per second at ~0.12 and ~0.05 respectively. This is important to avoid double 
occupancy during signal acquisition.  
Because the goal of this project was to transduce and enumerate the presence of 
CTCs selected from whole blood, we anticipated that trace levels of white blood cells or 
red blood cells may be present in the sample to be interrogated using conductivity 
detection due to the high abundance of these cell types compared to the CTCs. For 
example, in 1 mL of whole blood, the number of white blood cells (WBCs) can be on the 
order of >106, and the red blood cell (RBCs) population could be >109.13   In this same 1 
mL of whole blood, the CTC abundance can be as low as <10 cells. Even if molecular 
recognition of particular integral membrane proteins specific for the CTCs were used to 
capture these cell types, residual WBCs or RBCs may be present due to non-specific 
types of interactions. The presence of these cells could give rise to false positives. 
Therefore, we investigated the ability of our conductivity detector to transduce WBCs 
and RBCs. 
Measurement of WBC cell suspensions containing 150 cells/µL was carried out 
with the conductivity detector using a flow rate of 0.05 µL/min. Figure 5.8   shows the 
resulting conductivity response, clearly indicating that no signal were observed as these 
cells traversed through the electrode pair. Video microscopy revealed that the cells 
were traveling through the micro-electrodes, but during their observed travel, no 
conductivity signal from these cells was observed.  
We next evaluated the ability of the conductivity detector to transduce RBCs.  
Conductivity measurement of RBC sample concentration of 150 cells/µL was generated; 





















































Figure 5.6 Conductivity response from MCF-7 cells ([cell] = 146 cells/ µL using tris-
glycine buffer as the suspension medium and at a flow rate of 0.05 µL/min. Upper panel 
shows signal obtained over 1000s with a total of 122-cells registered from the volume 
processed (0.83 μL), the lower panel shows the signal over the first 200s. Experiments 
were run at a sampling time 0.1s using ±5µA AC current, ±0.5 bipolar voltage, and 
40KHz frequency. 
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changes were observed as the RBCs traversed the electrode pair. The travel of single 
RBCs through the electrode pair was again verified using video microscopy.  
The absence of signals produced for the RBCs and WBCs in the present case is 
due to both the electrical properties of these cells and their morphology (i.e., cell size).  
In the present case, the conductivity response that is elicited is due to changes in the 
bulk solution conductance of the volume present between the electrode pair when 
single cells are resident within this volume. In the case of the tumor cells, their larger 
sizes compared to the WBCs and RBCs induces a larger perturbation on the measured 
conductance when they are resident in this interstitial space. For example, the average 
volume size of a CTC is 14 pL (d = 30 µm), for a RBC it is 0.06 pL (d = 5 µm) and finally 
the WBC volume is 1.7 pL (d = 15 µm).  In our case, the interstitial volume between the 
electrodes is 226 pL and therefore, a CTC occupies 7% of this interstitial volume, while 
for RBCs it is only 0.03% and 0.7% for the WBC. Therefore, more buffer and its ionic 
components are displaced when a CTC is resident between the electrodes as 
compared to a RBC or WBC. In addition, the high ionic content of tumor cells and their 
low membrane potentials provides a much higher conductivity compared to RBCs and 
WBCs. These factors indicate that a much larger perturbation on the bulk solution 
conductance is affected when a tumor cell is present in the probing volume. While the 
RBCs and WBCs do produce a difference in the bulk solution conductance when they 
are resident in the probing volume, the perturbations is below the SNR of the 
measurement and as such, are not seen. Scaling down the size of the probing volume 
by reducing the electrode size and spacing would provide better opportunities for 
transducing these cells (i.e. in cases  where their signals is vital, for example in 
apoptosis study) using conductivity detection.   
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5.3.3 Calibration Plot 
To establish the counting efficiency of our detector with regards to CTCs, 
different cell densities (10 -250 cells/µL, in tris-glycine buffer) were measured using the 
same experiment conditions (±0.5 V bipolar voltage, ±5 µA AC current, 40 KHz 
frequency and 0.05 µL/min flow rate). Five replicate measurements were averaged and 
a calibration plot was constructed (see Figure 5.9). The obtained slope (0.998) and 
correlation coefficient (r = 0.9998) clearly indicates the high accuracy and precision of 








Figure 5.7 Video frame image acquired with video microscope showing a tumor cell as 





























Figure 5.8 Conductivity response from WBCs (cell density =150 cells/µL in tris-glycine 
buffer) and RBCs (cell density = 150 cells/µL in tris-glycine buffer). Both cell 
suspensions were run at 0.05 µL/min flow rate using ±0.5V bipolar voltage, ±5 µA AC 
current and 40 KHz frequency.   
 





















Number of MCF-7 per μL  
Figure 5.9 Calibration plot of different cell (MCF-7) densities (10 - 250 cells/µL in Tris 
Glycine bufer). Results were average from five replicate measurements of each sample 
processed at 0.05 µL/min flow rate  using ±0.5V bipolar voltage, ±5µA AC current, and 
40 KHz frequency ( m = 0.998, r = 0.9998).  
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5.4 Integration of the Conductivity Detection System with a High Throughput     
Microsampling Unit (HTMSU) for CTCs Detection in Clinical Samples 
 
 The detection system herein reported was recently integrated with a high 
throughput microsampling unit (HTMSU) for label-free enumeration of isolated CTCs 
from whole blood.57 The HTMSU contains 51 microsampling units (MSU), which were 
fabricated in PMMA and decorated with monoclonal antibody to specifically isolate 
CTCs from whole blood (see Figure 5.10). As a model clinical sample, citrated blood (1 
mL) was seeded with 10 CTCs (MCF-7 breast cancer cell line) and processed with the 
HTMSU. Subsequently, a proteolytic CTC releasing buffer (Trypsin-tris-Glysine Buffer) 
was used to detach the captured CTCs from the HTMSU for label-free enumeration with 
the integrated conductivity sensor. In this study, 8 CTCs were successfully counted (see 
Figure 5.10E), which demonstrated high efficiency detection. In a similar assay, the 
system has been employed in enumerating prostate cancer cells (LNCaP) from blood 
samples.  
5.5 Conclusion and Future Work 
  A highly sensitive integrated conductivity detector system consisting of a pair of 
Pt electrodes was developed for a PMMA-based microfluidic device to identify and 
enumerate CTCs isolated from clinical samples. The detector was able to detect CTCs, 
but due to scaling issues and their electrical properties, RBCs and WBCs could not be 
transduced. This is particularly attractive in this application, since the device is targeted 
for transducing CTCs and thus, will eliminate false positive signals generated from 
these interfering species. In addition, the conductivity transduction modality adopted 
herein will generate precise and accurate quantitative measurements of tumor cells 
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without the need for cell staining. This has already been demonstrated with high 


















Figure 5.10 Top (labeled a) is the schematics of the HTMSU showing the integrated 
conductivity sensor (labeled b), a single port exit for detached cells (labeled c) and the 
sinusoidal cell capture channels (labeled d). Bottom (labeled e) is the conductivity 
response from a 1.0 mL of whole blood spiked with 10 CTCs and processed in the 
HTMSU followed by detachment  (using a releasing buffer that was hydrodynamically 
pumped through the device at a flow rate of 0.05 μL/min) and enumeration of the CTCs. 
8 CTCs were scored as indicated by the arrow. Adapted with permission.57 



















from whole blood associated with breast cancer,57 and Prostate cancer (see section 
5.4). In the experiment reported herein, tumor cells, RBCs and WBC were only used as 
examples; the detector can be configured to other application areas as well, such as 
selecting biopathogens from environmental or clinical samples. Furthermore, the 
detection system can serve as a tool for investigating the efficacy of therapeutic agents 
by monitoring CTCs from blood samples of patients under clinical management. This 
could expand its utility to clinical evaluation of drug candidates in the drug discovery 
process (e.g. clinical trial).  
We are currently working on the detection and quantification of pathogens and 
bacteria in environmental samples as well as biological samples with a careful 
manipulation of their electrical properties. Tumor cells of epithelia origin including those 
of liver, colon, duodenum, bladder, Lung and stomach are currently being cultured for 
further application of this method. The detection and quantification of these mixed cells 
will be followed with molecular profiling using a highly sensitive fluorescence detection 
method for diagnostic information (see Chapter 2).  
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SUMMARY AND FUTURE WORK 
6.1  Summary 
Microfluidics and single molecule detection (SMD) technologies were integrated with 
wide-field fluorescence technology to provide the ability to monitor biochemical 
reactions in a high throughput format with single molecule sensitivity. This integration of 
unique technologies presents an approach to revolutionize the drug discovery process 
through massive parallelization of processing units to increase data production rates 
while at the same time generating assay results with high statistical accuracy. The 
economic advantage of this integrated technology brought about by the exquisite 
capability for sample miniaturization to conserve precious biological reagents will 
undoubtedly minimize the cost of registering a validated drug for therapeutic 
administration. In addition, the system eliminates several bottlenecks associated with 
current technology for high throughput screening (HTS), which will greatly reduce 
automation complexities in drug discovery.  
 Background information related to SMD with emphasis on single molecule 
fluorescence was outlined in chapter 1. A thorough explanation of the basic principle of 
SMD together with the photophysical phenomena that impact fluorescent signal from 
single molecules was presented. In addition, Advances in single molecule fluorescence 
technology and its biochemical applications as well as the merger of microfluidics to 
SMD were discussed and reviewed.   
 In chapter 2, the design, performance and application of a novel wide-field optical 
system for high throughput SMD configured in a continuous flow format using 
microfluidics was presented. The system consisted of a microfabricated polymer-based 
  163
multi-channel fluidic network situated within the field-of-view (FoV) of the optical system 
for parallel sample processing. Photo transduction of molecular fluorescent signal was 
accomplished using an electron-multiplying CCD (EMCCD) operated in a frame transfer 
mode that allowed tracking single molecules as they passed through the illumination 
zone, as well as allowing for high speed data acquisition with 100 % duty cycle. The 
system was used to monitor biochemical reactions with single molecule sensitivity in a 
high throughput format. 
 In chapter 3, a novel cyclic olefin copolymer (COC) core waveguide embedded in 
PMMA and situated orthogonal to multiple fluidic channels along the width of a PMMA 
wafer was constructed and described. The waveguide system allowed for fluorescence 
detection from multiple fluidic channels using evanescent excitation and a CCD camera 
for parallel readout. Two methods of launching light into the embedded waveguide were 
evaluated; the use of a monolithic prism for effective laser launch into the waveguide 
and the use of an optical fiber coupled to the waveguide. The two designs generated a 
sufficient evanescent field for the wide field excitation of fluorescent dyes traveling 
above the waveguide in fluidic channels, which enabled reading fluorescent signal from 
multiple fluidic channels in a parallel format. 
 In chapter 4, a high density fluidic device with series of individual sample 
processors (fluidic network), configured in a small footprint suitable for optical imaging, 
was presented. The polymer microchip possessed multiple fluidic processors with an 
individual input reservoir for multi-sample analysis. An ultrasensitive fluorescence 
detection system with a large field-of-view (FoV) was used to transduce fluorescence 
signal simultaneously from each fluidic processor onto the active area of an electron 
multiplying charge coupled device (EMCCD). The utility of the multichannel network for 
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HTS with an optical system for producing the prerequisite sensitivity was demonstrated 
by parallel detection of fluorescent and non-fluorescent samples in the individual fluidic 
processors. In the present configuration, the fluidic system was characterized with 50-
fold increase in sample throughput and a projected 400-fold increase with slight 
modification in channel dimensions. 
 In chapter 5, the construction of a novel microfluidic device with integrated 
conductivity sensor for quantitative enumeration of circulating tumor cells (CTCs) was 
described in detail. The system was designed to transduce conductivity signal from the 
few copies of CTCs present in blood without interference from the vast amount of co-
existing erythrocytes and leukocytes. The conductivity transduction modalities 
generated precise and accurate quantitative measurements of tumor cells without the 
need for cell staining. The system presents an approach to the design of a viable tool 
for investigating the efficacy of therapeutic agents by monitoring CTCs in blood samples 
of patients under clinical management. 
6.2  Future Work 
6.2.1 HTS with APE1 as Therapeutic Target 
As alluded previously in chapter 4 (section 4.4), a combinatorial library of 
potential drug candidates will be screened against APE1, a target that has been linked 
to radio- and chemo-resistance in human tumors. An oligonucleotide duplex will be 
designed to possess the apurinic (AP) site recognized by APE1. The substrate will be 
labeled with a fluorophore at the 5’-end of the sense strand and a quencher at the 3’-
end of the antisense strand (see Figure 3.5). The high density fluidic device presented 
in chapter 4 and the optical system presented in chapter 2 will be employed in the 
screening experiments to monitor fluorescence signal from individual reactor channel 
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resulting from molecular perturbation in the substrate due to the activity of the enzyme 
in the presence of a small molecule inhibitor.  
6.2.2 HTS with L1-Endonuclease (L1-EN) as Therapeutic Target 
Similar to the assay described above, a library of small molecule inhibitors will be 
screened against L1-EN. In this case, the substrate will be designed to possess the 
consensus site (AATTTT motif) recognized by this enzyme (L1-EN).  
6.2.3 Throughput Enhancement via Increased Fluidic Channel Density 
A slight modification in the dimensions of the fluidic device presented in chapter 4 
will be adopted to increase the number of individual reactor channels (increase the 
packing density of the channels) that can be probed in parallel using our optical system  
to further increase throughput in our HTS campaign. The production of a 1 μm wide 
channel (pitch = 1 μm) has commenced, which will allow interrogation of 100 vias when 
the system is operated with FoV of 200 μm, and 200 vias when the system is operated 
with FoV of 400 μm. The channel dimensions will be driven further to 500 nm (pitch = 
500 nm), which will double the throughput by allowing interrogation of 200 vias and 400 
vias using FoV of 200 μm and 400 μm respectively. These throughputs are higher than 
anticipated from our proposed microfluidic system for HTS (see Introduction: section 
1.5, Figure 1.3). 
6.2.4 Integration of the High Density Fluidic Network with Embedded Orthogonal 
Waveguide 
 
The high density fluidic network described in chapter 4 will be integrated with the 
embedded orthogonal planar waveguide described in chapter 3. This integration will 
provide a system that will enhance fluorescence sensitivity in our HTS experiments. 
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6.2.5 Fluorescence Multiplexing Using Two-color Detection 
The next goal of this project will be to modify the optical detection system 
presented in chapter 2 for two color detection. To achieve this color multiplexing 
capability, a spectrograph will be incorporated into the optical system for spectral sorting 
of fluorescence from different molecular species using two excitation sources. The two 
color excitation sources have already been constructed and shall be built upon to 
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